CURRICULUM VITAE JOHN T. SINNOTT, MD, FACP Mailing Address: Division of Infectious Disease & International Medicine 1 Tampa General Circle Tampa, Florida 33606 (813) 844.4174 Office (813) 844.7605 Fax [email protected] www.instituteid.com James Cullison Professor of Medicine Associate Dean, USF Medicine International Director, Division of Infectious Disease and International Medicine Department of Internal Medicine, College of Medicine, University of South Florida Co-Director, Signature Interdisciplinary Program in Allergy, Immunology and Infectious Disease Education: University of South Alabama College of Medicine, Mobile, Alabama, 1978, MD University of South Florida, Tampa, Florida, 1973, Microbiology, MA Academic Positions: Co-Director, Interdisciplinary Program in Allergy, Immunology and Infectious Disease, 2005 – present Associate Dean, USF Medicine International, 2005 – present Professor, Global Health, College of Public Health, 2005 – present James Cullison Professor of Medicine, University of South Florida, 2000 – present Professor, Internal Medicine, University of South Florida, 1994 – present Director, Division of Infectious Disease and International Medicine, Department of Internal Medicine, University of South Florida, 1991 – present Teaching Faculty, University of South Florida Center for HIV Education and Research, University of South Florida, 1991 – present Director, Florida Infectious Disease Institute, 2004 – 2006 Associate Professor, Internal Medicine, University of South Florida, 1989 – 1994 Infectious Disease Coordinator, Tampa General Hospital and University of South Florida College of Medicine, 1985 – 1991 12/12/2011 CURRICULUM VITAE John T. Sinnott, MD, FACP 2 Assistant and Associate Adjunct Professor, Orthopedics, University of South Florida College of Medicine, 1984 – 1990 Assistant Professor, Internal Medicine, University of South Florida College of Medicine, 1983 – 1989 Director of Clinical Research, Infectious Diseases and Tropical Medicine, University of South Florida College of Medicine, 1983 – 1985 Graduate Teaching Assistantship, Department of Biology, University of South Florida, 1971 – 1973 Postgraduate Training: Fellow, Infectious Diseases and Tropical Medicine, University of South Florida, Tampa, Florida, 1981 – 1983 Resident, Internal Medicine, University of South Florida, Tampa, Florida, 1978 – 1980 Board Certification and Licenses: Diplomate, American Board of Internal Medicine, Infectious Disease Subspecialty, 1984 Diplomate, American Board of Internal Medicine, 1983 National Board of Medical Examiners, 1978 Private Pilot, Instrument, Federal Aviation Administration (Single and multi-engine, highperformance, complex) (current) Ships Master (multi-ton vessel), United States Coast Guard, Department of Transportation, current Hospital Appointments: Epidemiologist, Shriner's Children's Hospital, 1987 – present Director of Epidemiology and Employee Health, Tampa General Hospital, 1985 – present Chief of Staff, Tampa General Hospital, 1994 – 1996 Vice–Chief of Staff, Tampa General Hospital, 1992 – 1994 Secretary–Treasurer, Medical Staff, Tampa General Hospital, 1990 – 1992 Chief, Department of Internal Medicine, Tampa General Hospital, Tampa, 1988 – 1992 Vice–Chief, Department of Internal Medicine, Tampa General Hospital, 1986 – 1988 Government Appointments: Senior Advisor to the Secretary of Health, State of Florida, Biodefense, 2001 – 2005 Member, State Formulary Committee, State of Florida, 1999 – 2003 Member, Citizen Healthcare Planning Team, Governor Crist Transition Team, 2006 – 2007 12/12/2011 CURRICULUM VITAE John T. Sinnott, MD, FACP 3 Laboratory Experience: Microbiology Quality Advisor, Tampa General Hospital, Tampa, Florida, Sept 1996 – Sept 2004 Director, Microbiology Laboratory, South Florida Regional Bone and Tissue Bank, Lifelink, Tampa, Florida, Jan 1989 – 2008 Contract Consultant & Quality Director, Clinical Microbiology, Tampa General Hospital, Tampa, Florida, Aug 1984 – Sept 1996 Editorial Activity: Editorial Advisory Board, Journal of Health Management, 2009 – present Editorial Advisory Board, Journal of Health Management, 2006 – present Medscape Editorial Board, 1999 – 2000 Associate Editor, Infections in Urology, 1991 – 2000 Editor-in-Chief, Infections in Medicine, 1994 – 2009 Medical Editor, Emedicine: Medicine, Obstetrics/Gynecology, Psychiatry, and Surgery, 1999 – 2000 Senior Editor, Antimicrobic and Infectious Diseases Newsletter, 1994 – 2000 Editorial Board, Infections in Medicine, 1992 – 1994 Co-Editor, Contagion, 1992 – 1994 Associate Editor, Infectious Disease Newsletter, 1989 – 1994 North American Editorial Board, Health Information Network. London, England, 1991 – 1992 Board Appointments: Board Member Ex Officio, Florida Health Science Center Inc. (Tampa General Hospital) Board of Directors, 2008 – present Trustee, University of South Florida Foundation, 2006 – present International Academic Advisory Board, Vivekananda Institute for Leadership Development, 2005 – 2008 Chairman of the Board, Food Tech, VIFL (NASDAQ), 2003 – present Trustee, Tampa General Hospital Foundation, 1994 – 1996. 2000 – present Member, Advisory Board, LifeLink of Florida, 1988 – present Trustee, Hillsborough County Community College Foundation, 2003 – 2006 Board Member, International Biologic Resources, 1995 – 1996 Board Member, Suncoast Aids Network, 1989 – 1993 Member, Board of Directors, Suncoast Florida AIDS Network, 1988 – 1991 12/12/2011 CURRICULUM VITAE John T. Sinnott, MD, FACP 4 Honors and Awards: Tampa General Hospital: Honorary Medical Staff Officer, 2001 Tree of Life Award, 1996 Founding Physician Award, Protective Care Unit, 1989 President's Circle of Excellence, 1987 – 1988 University of South Florida: Inspire by Example Award, USF Student Affairs, 2011 Dean‟s Academic Performance Award, 2008-2009 Charter Class Mentor, USF Health Leadership Institute, 2006 – present Faculty, Alpha Omega Alpha, 1989 – present Silver Performance Award for Outstanding Contributions, College of Medicine, Department of Internal Medicine, 2006 – 2007 Gold Circle Honoree, 2004 Honors and Awards Council, 1999-2002 Charge to the Graduating Class, College of Medicine, 2001 Charge to the Graduating Class, College of Medicine, 2000 Honorary Alumnus, Alumnae Association, 1998 Provost‟s Award, Faculty-Staff Scholarship Campaign, 1997 Lifetime Appreciation Award, Division of Infectious Diseases, 1996 Outstanding Service Award, Division of Infectious Disease, 1992 Most Outstanding Clinical Professor, 1987, 1988, 1989, 1990, 1991, 1992 (Award Retired and Renamed "John T. Sinnott Award for Outstanding Clinical Professor," 1992) Faculty Sponsor, Watson Clinic Award for Outstanding Senior Student Research, 1989, 1991, 1992 Fund-Raising Recognition Award, Faculty Staff Scholarship Campaign, 1990 2nd Place Award, Faculty Sponsor, Student Research Day, 1990 Founding Physician Award, Moffitt Cancer Center Institute, 1986 Outstanding House Officer Award, 1978 Phi Sigma Honor Society, Tampa, Florida, 1973 Other Awards: Health Care Educator Award, Tampa Bay Business Journal‟s Health Care Heroes, 2011 Citation: Leon G. Smith Infectious Disease Institute Hall Of Fame, 2000 – present 12/12/2011 CURRICULUM VITAE John T. Sinnott, MD, FACP 5 Citation: Naifeh S and Smith GW. The Best Doctors in America, 2001 - present Citation: Who‟s Who in America and Science and Engineering, 1997 – present Citation: International Who's Who for Professionals, 1996 – present Finalist, Physician Mentor Recognition Program, American Medical Association – Women Physicians Congress, 2007 Leadership Florida Distinguished Member Award, Tampa, Florida, 2007 Service Awards, Department of Homeland Security and Immigration Enforcement “In Recognition of ICE Training.” Presented by Phil Ashton, Immigration Customs Enforcement, Lantana, Florida, 2007 Lifetime Achievement Award, The AIDS Institute, for “Longtime Dedication to HIV/AIDS Prevention, Treatment, and Research in the United States and Internationally,” Tampa, 2006 Julia B. Williams Award for Service to Hillsborough County Community College Foundation, 2005 Because We Care Award, Florida Liver Association, Tampa, Florida, 2004 Leadership Florida Class XXI Graduate, 2003 Florida HIV/AIDS Red Ribbon Excellence Award, Bureau of HIV/AIDS, Florida AIDS Action, 2003 Citation: Best Doctors in Tampa, chosen by Doctors, Tampa Bay Magazine, February 2001, 2003 Finalist, Humanism in Medicine Award, Association of American Medical Colleges, 2001 Citation: Strathmore‟s Who‟s Who, 2001 Citation: Lexington Who‟s Who, 2000 National Beth Israel Humanism Award, NBI Healthcare Foundation, 1998 AIDS Education Award for Dedication and Support of AIDS Education, 1997 AIDS Service Award, FACT (For AIDS Care Today) St. Petersburg, Florida, 1997 Leadership in Medical Education Award, Florida Medical Association, Jacksonville, Florida, 1994 Physician Recognition Award, American College of Pathologists, Chicago, Illinois, 1992 Mayoral Proclamation, "Doctor Marvin R. Dunn and Doctor John T. Sinnott Day," for Contributions to College of Medicine, City of Tampa, Florida, May 29, 1992 Ciba Geigy Award for Outstanding Teaching, Ciba Geigy Corporation, Woodbridge, New Jersey, 1992 Honorary Organizing Committee, AIDS Project Quilt, Tampa, FL, 1989, 1992 Hillsborough County Board Public Institutions Award for Contribution to AIDS Education, Tampa, Florida, 1991 12/12/2011 CURRICULUM VITAE John T. Sinnott, MD, FACP 6 Philanthropic Award, Shriner's Hospitals for Crippled Children, Tampa Unit, Tampa, Florida, 1991 Clinical Associate Rotation, National Institutes of Health, National Institute of Allergy and Infectious Disease, Bethesda, Maryland, 1978 Microbiology Award, University of South Alabama College of Medicine, Mobile, Alabama, 1978 American Student Medical Association Prize for Research, 2nd Place, University of South Alabama College of Medicine, Mobile, Alabama, 1975 Hans Smetana Award, American Hepatic Association, New Orleans, Louisiana, 1974 Committees: James A. Haley Veterans Administration Hospital: Member, Acting Chair, Pharmacy and Therapeutics Committee, 1983 – 1988 Shriner’s Children’s Hospital: Chair, Infection Control Committee, 1987 – present Member, Institutional Review Board, Shriner's Crippled Children's Hospital, 1990 – 1994 Tampa General Hospital: Member, TGH Foundation Executive Committee, 2007 – present Chair, Infection Control Committee, 1985 – 1992, Member, 1992 – present Member, Cardiac Transplant Committee, 1985 – 2001 Member, Liver Transplant Committee, 1986 – 1999 Member, Clinical Executive Board, 1986 – 2001, Chair, 1994 – 1996 Member, Quality Assurance Committee, 1986 –1990, Chair, 1990 – 1992 Member, Pharmacy and Therapeutics Committee, 1985 – 1992 Member, Pediatric Heart Transplant Committee, 1989 – 1991 Member, Cardiac Transplant Research Committee, 1989 – 1991 Chair, Committee on Clinical Teaching Service, 1989 – 1991 Member, Bio-Ethics Committee, 1987 – 1991 Member, Heart and Lung Transplant Committee, 1986 – 1990 Member, Burn Unit Committee, 1988 – 1990 Member, Ad Hoc Nurse-Physician Liaison Committee, 1988 – 1989 Member, Ad Hoc Committee on Clinical Pharmacology, 1986 Member, Ad Hoc Committee on Cardiac Transplantation, 1985 12/12/2011 CURRICULUM VITAE John T. Sinnott, MD, FACP 7 University of South Florida College of Medicine: Mentor, Medical Student Learning Community Mentor Group, 2005 – present Member, AIMS Committee, University of South Florida, 2005 – present Member, Voluntary Faculty Promotion Committee, 1996 – present Chair, Dean's Task Force on AIDS, 1992 – 2002 Member, Departmental Promotion and Tenure Committee, 1990 – present Team Leader, Faculty/Staff Scholarship Campaign, University of South Florida, 1997, 2004 – 2005 Honors and Awards Council, 2000 – 2003 Committee on Medical Student Affairs, 2000 – 2001 Member, Nominating Committee, Faculty Association, 1991 –1995, 1998 Member, President‟s Council, Faculty/Staff Scholarship Campaign, University of South Florida, 1996 – 1997 Chair, Voluntary Faculty Promotion Committee, 1994 – 1996 Member, Roy H. Behnke Lectureship Honorary Committee, 1995 – 1996 College of Medicine Representative, University of South Florida –Tampa General Hospital Affiliation Committee, 1993 –1996 Departmental Representative for Medicine, Faculty Association, 1990 – 1996 Member, Dean's Implementation Committee, 1994 – 1995 Chair, Internal Medicine Research Review Committee, 1992 – 1994 Member, Committee on Committees, Faculty Association, 1990 – 1994 Member, Task Force for Continuing Medical Education, 1993 Member, Search Committee, Price Endowed Chair, Department of Pediatrics, 1992 –1993 Chair, Committee on Goals and Objectives, 1990 – 1993 Member, Transplant Oversight Committee, 1986 –1993 Member, College Promotion and Tenure Committee, 1990, Chair, 1991 –1992 Member, Institutional Life and Culture Task Force, University Honors Program, 1990 – 1992 Member, LCME Self-Study Committee on Faculty, 1991 Member, Search Committee, Director of Orthopaedics, 1991 Member, Faculty Senate, 1988 – 1990 Member, Saunders' Scholarship Committee, 1988 – 1989 Chair, Student Affairs Task Force, 1989 Member, AIDS Committee, 1987 – 1988 12/12/2011 CURRICULUM VITAE John T. Sinnott, MD, FACP 8 Miscellaneous Committees: Co-Chair, Public Policy Track, United States Conference on AIDS, Houston, Texas, October 2005 Member, Finance Committee, Society for Healthcare Epidemiology, Mt. Royal, New Jersey, 1997 – 2000 Member, Finance Committee, Infectious Disease Society of America, Arlington, VA, 1996 – 1998 Member, Medical Health Advisory Panel, Museum of Science and Industry, 1993 Member, Hillsborough County AIDS Coordinating Council, 1990 – 1992 Teaching Activities: Director Leader Scholarly Concentration in Public Health: Global Approaches to Clinics and Communities, 2007 – present Colloquium II: Global Medicine, 2007 – present PHC 6510 Exotic and Infectious Diseases, College of Public Health, Lecturer, 2004 – 2008 BMS 6920 Colloquium I/II, College of Medicine, Lecturer, 2004 – present MEL 8371 Selected Topics in Infectious Disease, 1991 – present MEL 8357 Infections in Transplant Medicine, Course Director, 1988 – present BMS 6810 Introduction to Clinical Medicine, Lecturer, 1983 – present BCC 6110 Internal Medicine Clerkship, Attending, 1983 – present MEL 9999 Independent Study in Infectious Diseases, Course Director, 1983 – present MEL 8334 General Internal Medicine Clerkship, Honors Program, 1991 – 1992 MEL 7310 Infectious Disease and Tropical Medicine, Course Director, 1983 – 1991 MEL 7815 Honors Surgery Rotation, Lecturer, Core Curriculum on Surgical Infections, 1991 Volunteer Activities: Co-Chair, Faculty-Staff Scholarship Campaign, University of South Florida College of Medicine, Tampa, Florida, 1989, 1995, 2004 – 2010 Founder and Advisor, TGH Foundation Scholars Awards for Medical Students, Tampa, Florida, 1990 – present Founder and Advisor, Tampa General Hospital Medical Staff Scholarship Awards for Medical Students, Tampa, Florida, 1989 – present Numerous Media Interviews and Programs, 1985 – present 12/12/2011 CURRICULUM VITAE John T. Sinnott, MD, FACP 9 Guest Lecturer, More Health, Tampa, Florida, 1995 – 2000 Co-Founder and Advisor, Students Teaching AIDS to Students (STATS) Program, University of South Florida, Tampa, Florida, 1987 – 1997 Chairman‟s Award for Outstanding Performance, Faculty-Staff Scholarship Campaign, 1995 Guest Lecturer, Tampa Sertoma Club, Tampa, Florida, 1995 Founder and Co-Director, University of South Florida Health and Rehabilitative Services Volunteer HIV Clinic, Tampa, Florida, 1992 – 1994 Project Beautiful, Tampa General Healthcare, Tampa, 1994 Founder and Advisor, University of South Florida Housestaff/Tampa General Hospital "Silver Platter CD" Literature Search Network, Tampa, Florida, 1988 – 1993 Chair, Tampa Bay Medical AIDS Task Force, Tampa, Florida, 1987 – 1990 Volunteer, Judeo-Christian Clinic, Tampa, Florida. 1978 –1989 Consultant, Health Care Task Force: AIDS and the Public Hospital. Florida House of Representatives, Miami, Florida, 1987 Founder, Protective Care Unit, Tampa General Hospital, Tampa, Florida, 1985 Guest Lecturer, Center for Organizational Development, University of South Florida, Tampa, Florida, 1985 Founding Board Member, Franklin Memorial Free Clinic, Mobile, Alabama, 1974 – 1977 Guest Lecturer, Medical Explorer Scouts, Mobile, Alabama, 1975 – 1976 Laboratory Volunteer, Clearwater Free Clinic, Clearwater, Florida, 1974 2011 Student Advisees: 2011 Fellow Advisees: Jane Mai Jesse Kresak Leela Mundra Asa Oxner Hena Waseem Michelle Heck Andrew Myer Moise Carrington, MD Elvis Castillo, MD Ulyee Choe, DO Rachel Franck, MD Joseph Katta, DO Elias Maroun, MD Tienchai Narach, MD Georgina Nasr, MD Luis Rosas, MD Kevin Smith, MD International Activities: Publications: 1. Naik E, Casanas B, Pazare A, Wagale G, Sinnott JT, Salihu H. Cost of Treatment: The Single Biggest Obstacle to HIV/AIDS Treatment Adherence in Lower-Middle Class Patients in Mumbai, India. Indian J Sex Transm Dis 2009; 30:23-7 12/12/2011 CURRICULUM VITAE John T. Sinnott, MD, FACP 10 2. *Tucci V, Sinnott JT. A Likely Case of Trichomonal Urethritis Contracted by Oropharyngeal Exposure. Asian Biomed 2008; 2(2):147-149 3. *Houseknecht K, Oliva AM, Sinnott JT. Contact Lens-Associated Fusarium Keratitis: an Eye for Trouble. Asian Biomed 2008; 2(1):35-42 4. Pujari SN, Dravid A, Naik E, Bhagat S, Tash K, Nadler JP, Sinnott JT. Lipodystrophy and Dyslipidemia among Patients Taking First-line, World Health Organization-recommended Highly Active Antiretroviral Therapy Regimens in Western India. J Acquirimmune Defic Syndr 2005; 39:199-202 5. Naik E, Karpur A, Taylor R, Ramaswami B, Ramachandra S, Balasubramaniam B, Galwankar S, Sinnott JT, Nabukera S, Salihu HM. Rural Indian Tribal Communities: an Emerging High-risk Group for HIV/AIDS. BMC International Health and Human Rights 2005 Feb 21; 5(1):1 6. Sinnott, JT. International Infectious Diseases [Foreword] 2001; 54:157 International Presentations & Abstracts: 1. Sinnott JT, Georgiev H, D‟Souza K, Mundra L, Sistrunk R, Pytlarz J, Wooley J, Lakshmi S. A University-Corporate Partnership to Enhance Vaccination Rates among the Elderly: An Example of Corporate Public Health Delivery. Presented to Options for the Control of Influenza VII Conference, Hong Kong, China, 2010 2. Pujari S, Dravid A, Gupte N, Dhananjay A, Menezes L, Sinnott J. Effectiveness and Safety of Generic Second-line PI-based ART in Western India. Boston: 15th Annual Conference on Retroviruses and Opportunistic Infections, 2008 3. Pothiawala S, Menezes L, Deshpande A, Joshi A, Kim H, & Sinnott J. Depressive symptomatology and suicidal ideation among HIV-infected women in India. Presented at the IV Annual IAS Conference on HIV Pathogenesis and Treatment, Sydney Australia, 2007 4. Pujari s. Gupte N, Mellinkeri S, Naik E, Menezes L and Sinnott J. Immunologic recovery amongst virologically suppressed HIV infected individuals in Western India. Los Angeles: 14th Annual Conference on Retroviruses and Opportunistic Infections, 2007 5. Pujari S, Wills T, Naik E, Menezes L, Nadler J, Norris D, Sinnott JT. Correlates of anemia for HIV patients in the HAART era: A single-center ambulatory clinical cohort in Pune, India. Presentation at XVI International AIDS Conference, Toronto, 2006 6. Menezes L, D‟Souza KR, D‟Souza KM, Somboonwit C, Amin S, Sinnott JT. A socio-historical construction of the AIDS epidemic in India. Abstract: MOPE0724. Presentation at the XVI International AIDS Conference, Toronto, Canada, 2006 7. Pujari S, Bele V, Joshi K, Sawant S, Joshi S, Nadler J, Sinnott JT, Naik E, Debhade D. Effect of rifampicin hepatic induction on Nevirapine concentrations in Indian volunteers. Denver: Retroviruses and Opportunistic Infections, 2006 8. Menezes L, Raja T, Tash K, Naik E, Nadler J, Sinnott JT. Drug use fuels HIV and STDs in a semirural community in India. Rio de Janeiro: IAS Conference on HIV Pathogenesis and Treatment, 2005 12/12/2011 CURRICULUM VITAE John T. Sinnott, MD, FACP 11 9. Naik E, Tash K, D'Souza K, Menezes L, Pazare A, Wable G, Sinnott JT. Cost of treatment: The single biggest obstacle to treatment adherence in middle class Mumbai, India. Rio de Janeiro: IAS Conference on HIV Pathogenesis and Treatment, 2005 10. Oehler RL, Mastorides SM, Toney JT, Gompf SG, Sinnott JT. Comparison of the Treponemal IgG assay versus conventional RPR analysis in patient screening for the diagnosis of Syphilis. The Challenge, International Society for Sexually Transmitted Disease Research Congress, Amsterdam, 2005 11. Desai B, Desai M, Naik E, Nadler J, Galwankar S, Tash K, Shah V, Sinnott JT. Can cervical neoplasia be prevented in HIV patients? Bangkok: International AIDS Conference, 2004 12. Desai B, Desai M, Naik E, Nadler J, Galwankar S, Tash K, Shah K, Sinnott JT. The Effect of prayer on Depression in HIV patients. Bangkok: International AIDS Conference, 2004 13. Persad A, Galwankar S, Shah V, Sharma A, Naik E, Pathak S, Sinnott JT. Preliminary Results of the RIHIBlooD Study in Gujarat, India. Barcelona: International AIDS Conference, 2002 14. Singh R, Naik E, Yeolekar M, Taylor R, Galwankar S, Sinnott JT. Profile of Occupational HIV Exposures in Urban Hospital in Mumbai, India. Barcelona: International AIDS Conference, 2002 15. Karpur A, Naik E, Balasubramaniam R, Seetharam Munnireddy S, Taylor R, Galwankar S, Sinnott JT. Are Tribals in India at risk of HIV? Barcelona: International AIDS Conference, 2002 16. Sinnott JT, Houston SH, Montero J, Holt D, Slone C, Thadhani S, Reidinger M. Coronary artery bypass infection. Amsterdam: ICC, 2001 17. Sinnott JT, Houston SH, Larkin JA, Montero JA. Leg closure team and broad spectrum antibiotic prophylaxis reduces coronary artery bypass infection rate. Hong Kong: First International Congress of the Asia Pacific Society of Infection Control, 1999 18. Sinnott JT. Infectious diseases following natural disasters. [Speech] Istanbul: ESIDO9, European Society for Infectious Diseases in ObGyn, 1999 19. Sinnott JT. Infections in OB intensive care. [Speech] Istanbul: ESIDO9, European Society for Infectious Diseases in ObGyn, 1999 20. Sinnott JT. Nosocomial gynecologic infections. [Speech] Istanbul: ESIDO9, European Society for Infectious Diseases in ObGyn, 1999 21. Larkin JA, Houston SH, Busciglio L, Sinnott JT. Staphylococcus epidermis endocarditis treated with RP59500. Barcelona: International Conference on the Macrolides, Azalides, Streptogramins and Ketolides, 1998 22. Sinnott JT, Holt DA, Houston SH, Bergen G, Sakalosky P, Larkin J, Oehler R. Clarithromycin as prophylaxis for MAC disease--a follow up. Lisbon: International Conference on the Macrolides Azalides and Streptogramins, 1996 23. Vincent AL, Ganguly R, Sanders LI, Sinnott JT, Majerus TC, Houston SH, Greene JN. A BRFSS-based survey of AIDS education and perceptions in Florida [Poster]. Yokohama: International Conference on AIDS - STDs, 1994 24. Sinnott JT, Houston SH, Majerus TC, Sanders LI, Bergen GA, Ganguly R: Clarithromycin in 500 mg BID as prophylaxis for MAC disease-A retrospective study [Poster]. Yokohama: International Conference on AIDS, 1994 12/12/2011 CURRICULUM VITAE John T. Sinnott, MD, FACP 12 25. Seeley P, Craig D, Cobian L, Sinnott JT, Greene JN. Health care worker's versus general public's knowledge of HIV information [Poster]. Yokohama: International Conference on AIDS, 1994 26. Vincent AL, Villanueva LP, Sinnott JT. An immunodiagnostic study of recurrent adeno lymphangitis and cellulitis ("erisipela") in the Dominican Republic, 1992 27. Walker JL, Gustke KA, Toney J, Sinnott JT. Centrifugation of antibiotic impregnated bone cement. Hamilton, Bermuda: Eastern Orthopedic Association, 1987 International Grants and Contracts: 1. Sinnott JT, Menezes L, Naik E, & Wills T. (2005). Training Program on Disaster Management, Emerging Infections and Trauma Care for Policy Planners and Physicians in Resource Limited Settings. Government of Maharashtra, India. ($55,200). 05/05-7/05 2. Sinnott JT, Menezes L, Naik E, & Wills T. (2004). HIV Management Training Program for Physicians in Resource Limited Settings. Government of Maharashtra, India. ($78,200). 09/0411/04 3. Sinnott JT, Menezes L, Naik E, & Wills T. (2004). Training Program for Policy Makers from Resource Limited Settings. Government of Maharashtra, India. ($15,000). 09/04-11/04 4. Sinnott JT, Naik E, Menezes L & Wills T. (2004). HIV Management Training Program for Policy Planners and Physicians in Resource Limited Settings. Government of Maharashtra, India. ($77,400). 6/04-7/04 International Agreements of Collaboration: University/Organization Universidad de Panama Universidad Latina de Panama Universidad de Carabobo Gansu Provincial Health Department Srinakharinwirot University Yeungnam University Escuela de Medicina de la Universidad Nacional Pedro Henriquez Urena (UNPHU) Policlínico La Vega, SA Instituto Tecnologico de Santo Domingo (INTEC) The Doctor Salvador B. Gautier Hospital The Directorate of Medical Education and Research, Government of Maharashtra Country Panama Panama Venezuela China Thailand South Korea Dominican Republic Dominican Republic Dominican Republic Dominican Republic India Year 10/09 10/09 10/09 01/09 11/08 05/08 10/07 Role Initiated & developed Initiated & developed Initiated & developed Initiated & developed Initiated & developed Initiated & developed Initiated & developed 02/07 Initiated & developed 10/06 Initiated & developed 05/06 Initiated & developed 2006 Initiated & developed 12/12/2011 CURRICULUM VITAE John T. Sinnott, MD, FACP 13 International Visiting Professorships Tianjin Infectious Disease Hospital, Tianjin, China, July 2011 Sinakharinwirot University, Nakorn Nayok, Thailand, December 2002, October 2007 Rungsit University, Thailand, October 2007 International Memberships: Editorial Advisory Board, Journal of Health Management, Indian Institute of Health Management Research, 2005-present International Academic Advisory Board, Vivekananda Institute for Leadership Development, 2005-present Other International Activities: Faculty Advisor, International Health Service Collaborative, USF Health, University of South Florida, Tampa, 2006 – present Program Advisor, Stephen Klasko Clinical Observership, Office of International Affairs and the Division of Infectious Disease, in collaboration with Yeungnam University, South Korea, 2008 Co-Host, Seven National HIV Updates for Indian Physicians, Pune, India, 2000 – 2007 Co-Sponsor, Seven Training Programs (105+ Indian Trainees) Ruby Hall Clinic, Pune, India, 2000 – 2007 Founder, Learning Center with Computer and Broadband Access, Mysore Medical College, Mysore, India, 2005 Invited Speaker, International Hepatitis B Symposium, Manila, 2005 Co-Sponsor, Training Programs on Disaster Management, Emerging Infections and Trauma Care for Policy Planners and Physicians (12 Indian Trainees) at University of South Florida, Tampa, 2005 Co-Sponsor, HIV Management Training Programs (38 Indian Trainees) at University of South Florida, Tampa, 2004 Founder, CHART-India Training Center, Swami Vivekananda Youth Movement, Mysore, India, 1998 Member, Aid to Russia Committee, Society for Hospital Epidemiology, Washington, DC, 1993 – 1996 Invited Lecturer, Conference on Preventive Medicine in the Caribbean, Pan American Health Organization, Nassau, Bahamas, 1992 Invited Lecturer, General Hospital and St. George's College of Medicine, St. George, Grenada, 1990 Invited Lecturer, Royal Marsden Cancer Hospital, London, England, 1989 12/12/2011 CURRICULUM VITAE John T. Sinnott, MD, FACP 14 Invited Lecturer, Aberdeen Royal Infirmary, Aberdeen College of Medicine, Aberdeen, Scotland, 1986 Invited Lecturer, As Salam International Hospital, Medical College IV, Cairo, Egypt, 1985 Invited Lecturer, Arab Contractors Medical Center, Medical College IV, Cairo, Egypt, 1985 International Awards: MEDSWU Honorable Award presented by the Medical Association of Thailand and the Faculty of Medicine, Srinakharinwirot University, International Medical Summit II, Bangkok, Thailand, 2010 Global Leadership Award presented by the HRH Princess Maha Chakri Sirindhorn, Bangkok, Thailand, 2008 Lifetime Achievement Award, The AIDS Institute, for “Longtime Dedication to HIV/AIDS Prevention, Treatment, and Research in the United States and Internationally, Tampa 2006 Medical Research Council of Maharashstra, India, HIV Update Award, 2006 Vasai Region AIDS Control Society, Significant Contribution to International Infectious Disease Issues, India, 2004 The Dr. K. Menda Memorial Oration Award, P.D. Hinduja National Hospital, Mumbai, India, 2003 Contribution Award, Indian Practitioner, Bombay (now Mumbai), India, 2001 Society Membership: Society of Hospital Epidemiologists of America, 1987 – present American College of Physicians (Fellow), 1985 – present Infectious Diseases Society of America (Fellow), 1984 – present American Society for Microbiology, 1983 – present American Medical Association, 1978 – present International Society for Heart Transplantation, 1985 – 2000 American Society for Transplant Physicians, 1989 – 1999 Florida Practitioners of Infection Control, 1986 – 1996 American Society for Tropical Medicine, 1992 – 1994 Physician's Association for AIDS Care, 1988 – 1994 American College of Physician Executives, 1985 –1994 Alabama Academy of Science, 1976 –1978 12/12/2011 CURRICULUM VITAE John T. Sinnott, MD, FACP 15 Publications: * = Peer-reviewed journal 1. Alrabaa S, Castillo E, Nguyen P, Somboonwit C, Sriaroon C, Sinnott JT, Shapshak P. West Nile Virus Review, in progress, 2011 2. Shapshak P, Somboonwit C, Sinnott JT, Commins D, Singer E, Levine AJ. GeneChromosome Locations of Neuropsychiatric Diseases. Bioinformation 2011; 7(7): 366-368 3. *Mouzakis J, Somboonwit C, Lakshmi S, Rumbak M, Sinnott JT, Cherpelis B, Keshishian J. Levamisole Induced Necrosis of the Skin and Neutropenia Following Intranasal Cocaine Use: A Newly Recognized Syndrome. J Drugs Dermatol 2011 Oct 1; 10(10): 1204-7 4. Shapshak P, Duncan R, Duran EM, Farinetti F, Minagar A, Commins D, Rodriguez H, Chiappelli F, Kangueane P, Levine AJ, Singer E, Somboonwit C, Chiappelli F, Sinnott JT. Gene Chromosomal Organization and Gene Expression in Neurons Microdissected from Basal Ganglia from Patients with HAD and HIVE. Bioinformation, in progress, 2010 5. Shapshak P, Duncan R, Duran EM, Farinetti F, Minagar A, Commins D, Rodriguez H, Chiappelli F, Kangueane P, Levine AJ, Singer E, Somboonwit C, Sinnott JT. Gene Expression for HIV-associated Dementia and HIV Encephalitis in Microdissected Neurons: Preliminary Analysis. Neurobehavioral HIV Medicine 2011; 3:53-78 6. Barkhordarian A, Iyer N, Shapshak P, Somboonwit C, Sinnott JT, Chiappelli F. Influenza 2009 Pandemic: Cellular Immunemediated Surveillance Modulated by TH17 and Tregs. Bioinformation 2011; 6(1):39-40 7. Shapshak P, Duncan R, Kangueane P, Somboonwit C, Sinnott JT, Commins D, Singer E, Levine A. HIV Associated Dementia and HIV Encephalitis II: Genes on Chromosome 22 Expressed in Individually Microdissected Globus pallidus Neurons (Preliminary Analysis). Bioinformation 2011; 6(5):183-186 8. Shapshak P, Chiappelli F, Somboonwit C, Sinnott JT. The Influenza Pandemic of 2009: Lessons and Implications. Mol Diagn Ther 2011 Apr; 15(2):63-81 9. Sowmya G, Shamini G, Anita S, Sakharkar M, Mathura V, Rodriguez H, Levine AJ, Singer E, Commins D, Somboonwit C, Sinnott JT, Siddhu H, et al. HIV-1 Envelope Accessible Surface and Polarity: Clade, Blood, and Brain. Bioinformation 2011; 6(2): 48-56 10. Shamini G, Ravishandran M, Sinnott JT, Somboonwit C, Sidhu H, Shapshak P, Kangueane P. Structural Inferences for Cholera Toxin Mutations in Vibrio cholerae. Bioinformation 2011 Mar; 6(1): 1-9 11. Sinnott JT, Somboonwit C, Oxner A. Clostridium tetani in a Haitian Refugee. Clin Microbiol Newsl 2011 Mar; 33(5): 37-39 12. *Shapshak P, Pandjassarame K, Fujimura RK, Commins D, Chiappelli F, Singer E, Levine A, Minagar A, Novembre F, Somboonwit C, Nath A, Sinnott JT. NeuroAIDS Review. Editorial. AIDS 2011; 25:123-141. 13. Shapshak P, Somboonwit C, Drumright LN, Frost S DW, Commins D, Tellinghuisen T, Scott W, Duncan R, McCoy C, Page JB, Giunta B, Fernandez F, Singer E, Levine A, Minagar A, 12/12/2011 CURRICULUM VITAE John T. Sinnott, MD, FACP 16 Oluwadayo O, Kotila T, Chiappelli F, Sinnott JT. Molecular and Contextual Markers of Hepatitis C Virus and Drug Abuse. Mol Diag Ther 2009; 13(3):153-79 14. Casanas BC, Pothiawala S, Sinnott JT. An Elderly Man with NOMA Orofacial Gangrene. Infect Dis in Clin Pract 2009; 17(3):208-209 15. *Joseph J, Sinnott JT. [Letter] Web Searches about Physicians. JAMA 2008 Nov 19; 300(19):2249-50 16. *Houseknecht K, Oliva AM, Sinnott JT. Contact lens-associated Fusarium keratitis: an eye for trouble. Asian Biomed 2008; 2(1):35-42 17. Hussamy D, Sinnott JT. [Book Review] Bone Morphogenetic Protein and Collagen. Cell Transplant 2006; 15(1):83-84 18. *Billington A, Sinnott JT. [Book Review] The Great Influenza. Infect in Med 2005; 22(8):375 19. Gompf S, Herman B, Tash K, Sinnott JT. Pseudomonas aeruginosa causing a corneal ulcer. Clin Micro News 2005; 27(8); 15:64-65 20. Vincent AL, Greene JN, Sinnott JT, Rojas CA. Group A Streptococcal Cellulitis with Lymphedema. Infect in Med 2005 Jul: 317 21. Pujari S, Sinnott JT, et al. Lipodystrophy and dyslipidemia among patients taking first-line, WHO-recommended highly active antiretroviral therapy regimes in Western India. J of AIDS 2005 Jun 1; 39(2):199-202 22. Laartz BW, Cooper C, Degryse A, Sinnott JT. A wolf in sheep‟s clothing: Advanced Kaposi‟s sarcoma mimicking a vulvar abscess. South Med J 2005 Apr; 98(4):475-7 23. Degryse A, Takagishi J, Sinnott JT. A swollen knee and tremor. Clin Pediatr 2004; 43(1):115-7 24. *Wills TS, Lavina J, Sinnott JT. Blastoschizomyces capitatus pneumonia in an immunocompetent male. South Med J 2004 Jul; 97(7):702-4 25. Elko L, Rosenbach K, Sinnott JT. Cutaneous manifestations of water borne infections. Curr Infect Dis Rep 2003 Oct; 5(5):398-406 26. *Gill JK, Field T, Vincent AL, Greene JN, Sandin RL, Sinnott JT. Antibiotic susceptibility among penicillin-resistant pneumococcal isolates in cancer patients. Infect in Med 2003; 20:9 27. *Vincent AL, Sinnott JT. Apparent per capita consumption of cigarettes by Florida counties. Fl J of Public Health 2003; 13:1 28. Tebes CC, Lynch C, Sinnott J. The Effect of Treating Bacterial Vaginosis on Preterm Labor. Infect Dis Obstet Gynecol 2003; 11(2):123-129 29. *Sinnott JT, Degryse A. Death and dying [Book Review]. JAMA 2003; 289(2):235-236 30. *Ganguly R, Lenox B, Quiroz E, Sinnott JT. HIV infection, risk factors, and testing in a veteran population. Amer Clin Lab 2002 Mar; 21(2):32-9 31. *Montero, JA, Zaulyanov, LL, Houston, S. H, Sinnott, JT. Chancroid: an update. Infect in Med 2002; 19:4 32. *Montero JA, Herman B, Bartels LJ, Sinnott JT. Tuberculous otitis. Infect in Med 2002; 19:2 33. *Rosenbach KA, Sinnott JT. Vaccines in the 21st Century. Infect in Med 2001; 18:8 12/12/2011 CURRICULUM VITAE John T. Sinnott, MD, FACP 17 34. *Vincent AL, Vincencio RP, Greene JN, Sandin RL, Sinnott JT. Botfly myiasis in a returning traveler. Infect in Med 2001; 18:3 35. *Montero JA, Sinnott JT, Holt DA, Lloyd C. Biliary cryptosporidiosis: current concepts. Infect in Med 2001; 18:312-316 36. Gill JK, Vincent AL, Greene JN, Sandin RL, Sinnott JT. A case-control study of antibiotic susceptibility among penicillin resistant pneumococcal infections in cancer patients. Infect in Med 2001 37. Bergen GA, Kanowitz SJ, Houston SH, Mbaga II, Sinnott JT. Invasive external otitis with bilateral renal dissemination caused by Aspergillus fumigatus. Infect in Urol 2000; 13(6):162-164 38. Reidinger M, Sinnott JT. Van Gogh: artist created or artist medicated? Medlennium 2000; 1:32 39. Sinnott JT, Houston SH. A time to die: the place for physician-assistance [Book Review]. JAMA 2000; 283:540 40. Sinnott JT. Survival tip. IFR The Magazine for the Accomplished Pilot 1999; 15:4 41. *Larkin JA, Lit L, Sinnott JT, Wills T. Infection of a knee prosthesis with Tsukamurella species. A case report. South Med J 1999; 92:831-2 42. *Vincent AL, Vicencio RP, Greene JN, Sandin RL, Sinnott JT. Botfly myiasis in a returning traveler. Infect in Med 1999 43. *Larkin JA, Minerva K, Sinnott JT. HIV primer [Book Review]. JAMA 1999; 281:24 44. *Cottam JA, Shenefelt PD, Sinnott JT, Stevens GL, Cancio M, Sakalosky PE. Common skin infections in the elderly. Infect in Med 1999; 16:4 45. *Mastorides SM, Oehler RL, Greene JN, Sinnott JT, Kranik M, Sandin RL. The detection of airborne mycobacterium tuberculosis using micropore membrane air sampling and polymerase chain reaction. Chest 1999 Jan; 115(1):19-25 46. *Sinnott JT, Kneer C, Holt D, Ganguly R. Exposure of medical students to body fluids. J of Am Coll Health 1999 Mar; 47(5):207-10 47. *Lynch CM, Sinnott JT, Shashy, RG, Murphy SJ. Acute fatty liver of pregnancy: a confusing clinical entity. Hospital Phys 1999 48. *Sarria JC, Sinnott JT, Martin DH. An AIDS patient with fever and a cough. Infect In Med 1998; 15:1 49. *Larkin JA, Ubillos SS, Sinnott JT, Houston SH. Infection prophylaxis after occupational exposure to HIV: a simple approach. The AIDS Read 1998; 8:3 50. *Ormerod LD, Sinnott JT, et al. Rapidly progressive herpetic retinal necrosis: a blinding complication of advanced AIDS. Clin Infect Dis 1998 Jan; 26(1):34-35 51. *Schwandt R, Callahan C, Greene JN, Sinnott JT, D‟Agostino A, Sandin RL. Actinomycosis mimicking metastatic lung cancer. Infect in Med 1997; (14)10: 791-98 52. *Lynch CM, Pinelli DM, Cruse CW, Spellacy WN, Sinnott, JT, Shashey RG. Maternal death from postpartum necrotizing fasciitis arising in an episiotomy: a case report. Infect Dis Obstet Gynecol 1997; 5(5):341-4 12/12/2011 CURRICULUM VITAE John T. Sinnott, MD, FACP 18 53. Vincent AL, Greene JN, Sinnott JT. Cigarette smoking and medical videotapes sold in pharmacies. J Am Pharma Assoc 1997 Nov-Dec; NS37(6):611-2 54. Glaser V, Hemming VG, Palmer AL, Sinnott JT. Bracing for the cold and flu season. Patient Care 1997; 9:47 55. *Martinez EJ, Cancio MR, Sinnott JT, Vincent AL. Survival of gastric mucormycosis in a renal transplant recipient. South Med J 1997 Mar; 90(3):341-4 56. Mastorides SM, Oehler RA, Greene JN, Sinnott JT, Sandin RL. Editorial: detection of airborne Mycobacterium tuberculosis by air filtration and polymerase chain reaction [Letter]. Clin Infect Dis 1997 Sep; 25(3):756-7 57. *Houston SH, Sinnott JT. Will microbes inherit the earth? [Editorial] Infect Med 1996; 13:770 58. Sinnott JT, Bergen GA. Update on clarithromycin: highlights and commentary from presentations at an international meeting. [Editorial]. Infect in Med 1996; 13:9 59. Sinnott JT, Larkin JA, Shashy RG. Death [Book Review]. JAMA 1996; 23:1921 60. *Bergen GA, Sakalosky PE, Sinnott JT. Transient aplastic anemia caused by parvovirus B19 infection in a heart transplant recipient. J of Heart Lung Transplant 1996 Aug; 15(8):843-5 61. Sinnott JT, Quinlan LA. Private office laboratories: coping with new federal guidelines [Editorial]. Infect in Urology 1996; 9:181 62. Bergen GA, Nadler JP, Houston SH, Gompf S, Sinnott JT. Nocardia Bacteremia: Case Reports and Review of the Literature. Infect Dis in Clin Prac 1996; 5:3 63. Yag-Howard C, Fitsmorris K, Pullara T, Sinnott J. Seabather‟s Eruption Developing in An Individual Not Directly Exposed to Sea Water. South Med J 1996; 89(10):S28 64. Nadler JP, Larkin JA, Saba S, Sinnott JT. Sepsis and meningitis caused by Capnocytophaga canimorsus in an immunocompetent host: case report and review of microbiology. Antimicrobics and Infect Dis News 1996; 15:25-26 65. Bergen GA, Gompf SG, Sakalosky PA, Sinnott JT. Influenza: more than Mom and chicken soup. J Fla Med Assoc 1996 Jan; 83(1):19-22 66. *Brown MA, Greene JN, Sandin RL, Hiemenz JT, Sinnott JT. Methlobacterium sp. bacteremia after infusion of contaminated autologous bone marrow. Clin Infect Dis 1996 Nov; 23(5):1191-2 67. *Foster J, Greene JN, Sandin RL, Sinnott JT, Spoto VM, Hitchcock CL, Karl R, Vincent AL. Small-bowel perforation in patients with AIDS: two case reports and a review of the literature. Infect Med 1996; 4:294 68. *Houston SH, Sinnott JT. Management of the transplant recipient with pulmonary infection. Infect Dis Clin North Am 1995 Dec; 9(4):965-85 69. *Cobian L, Houston SH, Greene JN, Sinnott JT. Moraxella nonliquefaciens septic arthritis in a patient undergoing hemodialysis. Clin Infect Dis 1995; 21:1039-1040 70. *Conrad MK, Sinnott JT, Albrink M, Sakalosky P. Gastric cancer: an infectious disease? Cancer Control 1995 Nov; 2(6):541-547 71. Sinnott JT, Thompson P. The expanding horizons of infection control [Letter]. Infect Cont Hosp Epidemiol 1995 Nov; 16(11):620 12/12/2011 CURRICULUM VITAE John T. Sinnott, MD, FACP 19 72. Karl FB, Mandelblatt D, Sinnott JT. One hundred years of medicine. Hillsborough County Med Assoc Bulletin 1995; l41: 3 73. Martinez EJ, Sinnott JT, McKeown PP, Nord HJ, Weinstein SS, Holt DA, Saba HI, Canedo M. Hemolytic anemia: a new herald for Kaposi's sarcoma in cardiac transplantation. South Med J 1995 74. *Riker AI, Cancio MR, Houston SH, Sinnott JT. Clostridium difficile osteomyelitis following traumatic leg injury. Infect Med 1995; 8:378 75. *Greene JN, Sinnott JT, Wyckoff, JA, Carter L, Sandin RL. Bacterial infection following blood product transfusion: some bad blood bugging you? Infect Med 1995; 4:165 76. Houston SH, Greene JN, Provencher DE, Ison MG, Sinnott JT. Mycobacterium leprae -an ancient scourge today. J Fla Med Assoc 1995 77. *Cobian L, Houston SH, Greene JN, Sinnott JT. Parainfluenza virus respiratory infection after heart transplantation successfully treated with ribavirin. Clin Infect Dis 1995 Oct; 21(4):1040-1 78. *Houston SH, Lipp K, Cobian L, Sinnott JT. Skin rash in a renal transplant recipient. Hospital Pract 1995 May 15; 30(5):89-90 79. Sinnott JT. We're working to reveal the best-kept secret [Editorial]. MedNotes 1995; 4:1 80. *Ubillos SS, Vuong D, Sinnott JT, Sakalowsky PE. Seabather's eruption. South Med J 1995 Nov; 88(11):1163-5 81. Sinnott JT. Sally's tips for sensitive doctoring [Letter]. J Fla Med Assoc 1994; 12:804 82. *Houston SH, Vincent AL, Cobian L, Sinnott JT. Strongyloides related sepsis in AIDS patients. Antimicrobics Infect Dis News 1994; 13:41 83. *McCloskey RV, Straube RC, Sanders C, Smith SM, Smith CR, Chess trial study group (Sinnott JT). Treatment of septic shock with human monoclonal antibody HA-1A. Ann Intern Med 1994; 121:1 84. *Sinnott JT, Mayer CA, Cancio MR, Powell C. Prions: a unique cause of transmissible dementias. Infect Med 1994; 11: 381 85. *Rushton TC, Ganguly R, Sinnott JT, Banerji M. Barriers to immunization-an examination of factors that influence the application of pneumococcal vaccine by house staff. Vaccine 1994 Oct; 12(13):1173-9 86. Sinnott JT, Ragsdale R, Bergen G, Padios MM. Probing for answers: DNA probes in infectious disease. J Fla Med Assoc 1994 Aug; 81(8):543-5 87. Sinnott JT, Rushton T, Holt DA, Freeman TB, Olanow CW, Sarzier JS. Infectious disease issues in fetal tissue transplantation for Parkinson‟s disease. Infect Dis News 1994; 12:65 88. *Houston SH, Greene JN, Padios MM, Cobian L, Sinnott JT. Suppurative thyroiditis. Infect Med 1994; 12:774 89. *Houston SH, Sinnott JT, Murphy SJ, Larkin JA, Greene JN. Chickenpox in pregnancy. Infect Med 1994; 8:564 12/12/2011 CURRICULUM VITAE John T. Sinnott, MD, FACP 20 90. *Sinnott JT, Greene JN, Kim E, Gompf SG. Hantavirus: an old bug learns new tricks. Infect Cont Hosp Epidemiol 1993 Nov; 14(11):661-4 91. Sinnott JT, Cancio MR, Lynch CM, Murphy SJ. Acute fatty liver of pregnancy presenting as hepatitis. West Med J 1993 92. Markowsky SJ, Sinnott JT, Houston SH. Selective decontamination of the digestive tract in intensive care patients. Infect Dis News 1993; 12:7 93. Sinnott JT. AIDS: palpating the pachyderm [Editorial]. Oracle 1993 94. Vincent AL, Holt DA, Houston SH, Sinnott JT. Fever and arthralgia in a medical student. Infect Dis News 1993; 12:6 95. Albrink MH, Sinnott JT. Laparoscopic cholecystectomy: infectious disease implications. Infect Dis News 1993; 12:6 96. Houston SH, Glossa JS, Fisher A, Montero J, Rushton TR, Sinnott JT. Immunization of the organ transplant recipient. Infect Dis News 1993; 12:86-87 97. Vincent AL, Cancio MR, Sinnott JT. Filariae and streptococci in "tropical lymphangitis" with lymphedema. Infect Dis News 1993; 12:7 98. Bowers VA, Sinnott JT, Flores R. Antibiotic interactions with FK506: a novel immunosuppressant. Infect Dis News 1993; 12:6 99. *Holt DA, JT, Baran DA, Oehler RL, Sinnott JT. Delta hepatitis: diagnostic algorithms. Infect Med 1993; 10:23 100. *Sinnott JT, Roskein D, Stern R, Bradley E. Intraamniotic infections: a major factor in preterm delivery. Infect Dis News 1993; 12:73 101. *Greene JN, Sandin RL, Villanueva L, Sinnott JT. Haemophilus parainfluenzae endocarditis in a patient with mitral valve prolapse. Ann Clin Lab Sci 1993 May-Jun; 23(3):203-6 102. *Oehler RL, Sinnott JT, Arepally G, Dunn YP. An unusual case of Kaposi's sarcoma mimicking cellulitis. Postgrad Med 1993 Dec; 94(8):139-44, 149 103. Holt DA, Sinnott JT, Van Sant S, Behnke RH, Lipp K. A medical history timeline. Florida medical society. J Fla Med Assoc 1993 Feb; 80(2):121-3 104. *Martinez EJ, Sinnott JT, Rodriguez-Paz, Oehler R. Lithium induced nephrogenic diabetes insipidus treated with indomethacin. South Med J 1993 Aug; 86(8):971-3 105. Sinnott JT, Gompf TC, Gonzalez-Gompf S. Congenital tuberculosis. Infect Dis News 1992; 2:5 106. *Hill DA, Sinnott JT, Holt DA, Cancio MR. A patient who got darker on zidovudine therapy. Hosp Pract 1992 Feb 28; 27(2A):29-30 107. *Sinnott JT, Cacciatore ML. Measles in pregnancy: physician on the spot. Infect Med 1992; 9:45 108. Sinnott JT, Barry KC. Dangerous marine life: how to deal with these injuries. Ocean Voyager 1992; 1:23 109. *Holt DA, Sinnott JT, Bradley EA. Nosocomial prostatitis. Infect Med 1992; 5:139 110. *Holt DA, Sinnott JT, Oehler RL, Bradley EA. BK virus. Infect Cont Hosp Epidemiol 1992 Dec; 13(12):738-41 12/12/2011 CURRICULUM VITAE John T. Sinnott, MD, FACP 21 111. *Sinnott JT, Oehler RL, Baran DA, Holt DA. Relapsing fever: ticked off by a lousy illness. Infect Med 1992; 9:18 112. *Chan G, Sinnott JT, Emmanuel PJ, Yandle S. Drug interactions with cyclosporine: focus on anti-microbial agents. Clin Transplant 1992; 6:141 113. *Esperanza L, Holt DA, Sinnott JT, Cancio MR, Bradley EA, Deutsch M. Murine typhus: forgotten but not gone. South Med J 1992 Jul; 85(7):754-5 114. *Taylor E, Sinnott JT. Ehrlichiosis. Infect Cont Hosp Epidemiol 1992 Feb; 13(2):104-6 115. *Holt DA, Sinnott JT, Toney JF, Greene JN. Chlamydia one dose treatment with azithromycin. Clin Research 1992; 40:2 116. *Finan M, Smith S, Sinnott JT, O'Brien W, et al. An interesting case presentation: peripartum meningococcal meningitis. J of Perinatology 1992 Mar; 12(1):78-80 117. *Chan GL, Kahana L, Weinstein SS, Sinnott JT. The effect of prophylactic aminoglycoside on early function in cadaveric renal transplant patients receiving cyclosporine. Pharmacotherapy 1992; 12:6 118. Sinnott JT. How does HCV antibody titer correlate with infectivity? [Letter].Cortland Forum 1991; 1:81 119. Russell DW, Cameron DJ, Lockey RF, Behnke RH, Sinnott JT, Ganguly R. Vaccine 1991 Sep; 9(9);691-2 120. Sinnott JT, Esperanza L, Holt DA, Thompson F. Hantavirus. Infect Dis News 1991; 10:51 121. Sinnott JT, Garland LL. Leuconostoc. Infect Dis News 1991; 10:33 122. *Lynch CM, Sinnott JT, Holt DA, Herold AH. Use of antibiotics during pregnancy. Am Fam Physician 1991 Apr; 43(4):1365-8 123. Lynch CM, Holt DA, Sinnott JT. Human parvovirus B19 and pregnancy. Infect Dis News 1991; 10:87 124. *Holt DA, Pattani NJ, Sinnott JT, Bradley EA. Lyme borreliosis. Infect Cont Hosp Epidemiol 1991 Aug; 12(8):493-6 125. *Sinnott JT, Albers SE, Holt DA. Postanginal sepsis with dysphagia. South Med J 1991 Mar; 84(3):385-6 126. *Ganguly R, Russell DW, Yangco BV, Chmel H, Cameron DJ, Sinnott JT. Influenza vaccination status among health care professionals for prevention of nosocomial infection in hospitalized elderly patients. Serodiagnosis and Immunotherapy in Infect Dis 1990; 4:309 127. *Larkin J, Sinnott JT, Weiss J, Holt DA. Human T-cell lymphotropic virus type-1. Infect Control Hosp Epidemiol 1990 Jun; 11(6):314-8 128. *Holt DA, Prieto J, Sinnott JT. Human herpes virus-6. Infect Dis News 1990; 9:17 129. *Sinnott JT, Emmanuel PJ. Mycobacterial infections in the transplant patient. Semin Respir Infect 1990 Mar; 5(1):65-73 130. *Sinnott JT, Alverez C, Greene J, Sweeney MJ, Holt DA. Nocardia brasiliensis cellulitis in a heart transplant patient. Texas Heart Inst J 1990; 17(2):133-5 12/12/2011 CURRICULUM VITAE John T. Sinnott, MD, FACP 22 131. *Sinnott JT, Cancio MR, Frankle MA. Tuberculous osteomyelitis masked by concomitant staphylococcal infection. Arch Intern Med 1990 Sep; 150(9):1865-7 132. *Sinnott JT, Rodnite J, Emmanuel PJ. Cryptococcus laurentii infection complicating peritoneal dialysis. Ped Infect Dis J 1989 Nov; 8(11):803-5 133. *Rogers KR, Sinnott JT, Ferguson JE. Using OKT3 to reverse cardiac allograft rejection. Heart Lung 1989 Sep; 18(5):490-6 134. Sinnott JT, Blazejowski C, Bazzini MD. Bordetella bronchiseptica endocarditis: a tale of a boy and his dog. Clin Microbiol News 1989; 11:14 135. *Sinnott JT, Rodnite J, Ruland R. What is it? Orbital or periorbital cellulitis? Postgrad Med 1989 May; 85(6):267-9 136. Toney JF, Sinnott JT, Ivey P. Infections in bone marrow transplantation. Infect Dis News 1989; 8:8 137. *Sinnott JT, Gasser S, Kilgore J: Tuberculosis Masquerading as Neoplasia: A Sheep in Wolf's Clothing. Hosp Pract 1989 Sept 15; 24(9):153-6 138. Sinnott JT, DiCarlo RL, Villanueva LP, Himelright IM. Infections in liver transplantation. Infect Dis News 1989; 8:57 139. *Sinnott JT, Wheedon C, Schwartz M. Post anginal sepsis: a pain in the neck. Postgrad Med 1989 Aug; 86(2):77-8, 81-2 140. Sinnott JT, Rushton T, Kilgore J. Infections in heart transplantation. III. Infect Dis News 1989; 8:57 141. *Sinnott JT, Himelright IM. Chlamydia species strain - TWAR. Infect Cont Hosp Epidemiol 1989 Apr; 10(4):175-7 142. *Sinnott JT, Coleman D, Cheek J, Rubin RW. Infections in renal transplantation. Infect Dis News 1989; 8:41 143. *Sinnott JT, Multhopp H, Leo J, Rechtine G. Yersinia enterocolitica causing spinal Osteomyelitis in a in a nonimmunocompromised host. South Med J 1989 Mar; 82(3):399-400 144. Sinnott JT, Carballo FE, Holt DA, Rubin RW. An introduction to organ transplantation. Infect Dis News 1989; 8:34 145. *Sinnott JT. Infections in the Rheumatic Diseases [Book Review]. J of Ortho Trauma 1989; 3:185 146. Sinnott JT, Turnquest DG, Milam MW. Plesiomonas shigelloides gastroenteritis. Clin Microbiology News 1989; 11:13 147. *Sinnott JT, Holt DA. Cryptococcal pyarthrosis complicating gouty arthritis. South Med J 1989 Dec; 82(12):1555-6 148. Sinnott JT, Blanco P, Cullison JP. Capnocytophagia: a case report. Infect Dis News 1988; 7:53 149. *Sweeney MS, Macris MP, Frazier OH, Peric M, Sinnott JT, McAllister HA. The treatment of advanced cardiac allograft rejection. Ann Thorac Surg 1988 Oct; 46(4):378-81 12/12/2011 CURRICULUM VITAE John T. Sinnott, MD, FACP 23 150. *Sinnott JT, Gilchrist L, Ellis L. Respiratory syncytial virus. Infect Control Hosp Epidemiol 1988 Oct; 9(10):465-8 151. *Sinnott JT, Cullison JP, Sweeney MS, Weinstein SS. Infections in patients receiving OKT3 monoclonal antibody for cardiac rejection. Texas Heart Inst J 1988; 15(2):102-6 152. *Walker JL, Gustke KA, Toney JF, Sinnott JT. Centrifugation of antibiotic impregnated bone cement. Orthopedics 1988; 6:891 153. *Sinnott JT, Cullison JP, Blanco P. Capnocytophagia. Infect Cont Hosp Epidemiol 1988 April; 9(4):170-3 154. *Sinnott JT, Cullison JP, Sweeney MS, et al. Respiratory syncytial virus pneumonia in a cardiac transplant patient. J Infect Dis 1988 Sep; 158(3):650-1 155. *Sinnott JT, Trout T, Berger L. The „swimming-pool granuloma‟ that wouldn't heal. Hosp Pract 1988 Feb 15; 23(2):82-4 156. *Sinnott JT, Milam M. Cholangitis 1987. Abdom Surg 1988; 30:16 157. *Sinnott JT, Cancio M. Rotavirus. Infect Control 1987 Dec; 8(12):519-21 158. *Sweeney MS, Sinnott JT, Cullison JP, Weinstein SS. The use of OKT3 for stubborn allograft rejection: an advance in clinical immunotherapy. J Heart Transplant 1987 Nov-Dec; 6(6):324-8 159. *Sinnott JT, Cullison JP, Sweeney MS. Candida (Torulopsis) glabrata. Infect Control 1987 Aug; 8(8):334-6 160. *Sinnott JT, Cullison JP, Rogers K. The treatment of cytomegalovirus gastrointestinal ulceration in a cardiac transplant patient. J Heart Transplant 1987 May-Jun; 6(3):186-8 161. Sinnott JT, Cancio MR. Cytomegalovirus. Infect Control 1987 Feb; 8(2):79-82 162. Sinnott JT, Feldman D. Chromo bacteriosis - Florida. MMWR, Centers for Disease Control 1981; 29:51 163. Sinnott JT, Craig CP. Endotoxin clearance by Kupffer cells in Venezuelan equine encephalitis infected mice. Alabama J of Med Sciences 1974; 80:1 Textbooks Chapters & Misc.: 1. Shapshak P, Singer E, Commins D, Chiappelli F, Levine A, Minagar A, Somboonwit C, Sinnott JT. Inflammation in NeuroAIDS. In progress, 2010 2. Wills T, Sinnott JT, Alrabaa S. Viral Hemorrhagic Fevers. APIC Text of Infection Control and Epidemiology, 3rd ed. Association for Professionals in Infection Control and Applied Epidemiology Principles and Practice (APIC). Washington, 2009 3. Asthana D, Fischl M, Sachdeva N, Teppler H, Sinnott J, Saag M. Host Response. In: Mildvan D ed. International Atlas of AIDS, 4th ed. Philadelphia: Current Medicine Group, 2008 4. Sinnott JT, Casanas B, Cooks A, Cooper C, et al. Abdominal Infections. In: MacCue J, Kahan S eds. In A Page Infectious Disease. Baltimore: Lippincott Williams & Wilkins, 2006 5. Sinnott JT. Vancomycin-Resistant Enterococcus. In: MacCue J, Kahan S eds. In A Page Infectious Disease. Pittsburgh: Lippincott, Williams & Wilkins, 2006 12/12/2011 CURRICULUM VITAE John T. Sinnott, MD, FACP 24 6. Somboonwit C, Poklepovic A, Irvine L, Sinnott JT. Infectious disease aspects of viral hemorrhagic fever. In: Soule BM ed. The American Practitioner in Infection Control. St. Louis: Mosby-Year Book, Inc., 2004 7. Houston SH, Sinnott JT. Hantavirus pulmonary syndrome. APIC Infection Control and Applied Epidemiology Principles and Practice. St. Louis: Mosby-Year Book, Inc., 2004 8. Degryse A, Houston SH, Sinnott JT. Dengue virus. In: Kean L, ed. Association for Professionals in Infection Control and Applied Epidemiology Principles and Practice. St. Louis: Mosby-Year Book, Inc., 2004 9. Rosenbach KA, Houston SH, Sinnott JT, Shea JP. Infectious disease aspects of employee (occupational) health. In Betts RF, Chapman SW, Penn RL, eds. Reese and Betts’: A Practical Approach to Infectious Disease, 5th ed. Philadelphia: Lippincott Williams & Wilkins, 2003:957 10. Houston SH, Rubin RH, Sinnott JT. Infections in transplantation. In: Betts RF, Chapman SW, Penn RL, eds. Reese and Betts’: A Practical Approach to Infectious Disease, 5th ed. Philadelphia: Lippincott Williams & Wilkins, 2003; 20:782 11. Rosenbach KA, Houston SH, Sinnott JT, Shea JP. Infectious disease aspects of employee (occupational) health: A brief overview. In: Reese RE, and Betts RF, eds. A Practical Approach to Infectious Diseases. Toronto: Little Brown, 2002 12. Houston SH, Sinnott JT. Infections in transplantation. In: Reese RE, and Betts RF, eds. A Practical Approach to Infectious Diseases, Toronto: Little Brown, 2002 13. Huguet K, Houston SH, Casatelli J, Sinnott JT. Dengue virus. APIC Infection Control and Applied Epidemiology Principles and Practice. St. Louis: Mosby-Year Book, Inc. 2000;118:6-11 14. Sinnott JT, Rosser WW, Williams ML, et al, eds. Clinical Internal Medicine. Peking, China: Chinese University Press, 1999 15. Larkin JA, Houston SH, Sinnott JT. Infections in transplant patients. In: Sharpe MD, and Gelb AW, eds. Anesthesia and Transplantation. Boston: Butterworth-Heinemann, 1999 16. Kim E, Sinnott JT. Hantavirus. In: Soule BM, ed. The American Practitioners in Infection Control Curriculum for Infection Control Practice. St. Louis: Mosby, 1996 17. Casetelli J, Ison M, Houston SH, Sinnott JT. Dengue virus. In: Soule BM, ed. The American Practitioners in Infection Control Curriculum for Infection Control Practice. St. Louis: Mosby, 1996; 81:7 18. Larkin JA, Houston SH, Sinnott JT, LeFor WM. Serologic screening of potential organ donors. UNOS Organ Procurement, Preservation and Distribution in Transplantation, 2nd Ed., Richmond: UNOS, 1996 19. Sinnott JT, Houston SH, Shea JP. Infectious disease aspects of employee health. In: Reese RE, and Betts RF, eds. A Practical Approach to Infectious Disease 4th ed. Boston, Toronto: Little Brown, 1996: [Appendix B] 1406-1416 20. Houston SH, Rubin RH, Sinnott JT: Infections in transplantation. In: Reese RE and Betts RF, eds. A Practical Approach to Infectious Disease 4th ed. Boston, Toronto: Little Brown, 1996; 20:785-811 21. Larkin JA, Houston SH, Sinnott JT. Skin infections in the elderly. In: Cooper JW, ed. Antiinfectives in the Elderly. Binghamton: The Haworth Press, Inc. 1995:51-67 12/12/2011 CURRICULUM VITAE John T. Sinnott, MD, FACP 25 22. Ison MG, Larkin JA, Houston SH, Sinnott JT. Fungal infections: Cryptococcus neoformans, Fungal infections: Histoplasma capsulatum, Fungal infections: Coccidioides immitis, Fungal infections: Aspergillus, Fungal infections: treatment of AIDS-related mycoses: a review of side effects and drugs. Jacksonville Florida Medical Association Clinical Manual on HIV and AIDS, 2nd ed. 1995 23. Larkin JA, Houston SH, Sinnott JT. Infections in the transplant patient. In: Sharpe M, ed. Anesthesia and Transplantation. Newton: Butterworth/Heinemann, 1995 24. Houston SH, Sinnott JT. Management of pulmonary infiltrates in the transplant recipient. In: Rubin RH, ed. Infectious Disease Clinics of North America. Philadelphia: WB Saunder, 1995 25. Holt DA, Sinnott JT, Kim E. Fever of unknown origin. In: Neu H, ed. Current Practice of Medicine. Philadelphia: Current Medicine Press, 1994 26. Sinnott JT, Rubin RH. Infections in transplantation. In: Reese RE, and Betts RF, eds. A Practical Approach to Infectious Disease, 3rd ed. Boston, Toronto: Little/Brown, 1991 27. Sweeney MS, Frazier OH, Sinnott JT, O'Connell JB. The use of monoclonal antibodies in treating cardiac allograft rejection: Our experience with OKT3. In: Reichart B, Fasol R, et al., eds. Recent Advances in Cardiovascular Surgery. Munich, Germany: R.S. Schulz, 1989 28. Sinnott JT, Cullison JP. Epstein-Barr virus (Revision). In: Soule BM, ed. The American Practitioners in Infection Control Curriculum for Infection Control Practice. Dubuque: Kendall/Hunt, 1988 29. Sinnott JT, Cullison JP. Varicella-zoster virus (Revision). In: Soule BM, ed. The American Practitioners in Infection Control Curriculum for Infection Control Practice. Dubuque: Kendall/Hunt, 1988 30. Sinnott JT, Cancio M. Cat scratch disease. In: Soule BM, ed. The American Practitioners in Infection Control Curriculum for Infection Control Practice. Dubuque: Kendall/Hunt, 1988 31. Sinnott JT, Cancio M. Respiratory Syncytial Virus (Revision). In: Soule BM, ed. The American Practitioners in Infection Control Curriculum for Infection Control Practice. Dubuque: Kendall/Hunt, 1988 32. Sinnott JT, Cancio M. Cytomegalovirus (Revision). In: Soule BM, ed. The American Practitioners in Infection Control Curriculum for Infection Control Practice. Dubuque: Kendall/Hunt, 1988 33. Sinnott JT, Cancio M. Herpes simplex virus. (Revision) In: Soule BM, ed. The American Practitioners in Infection Control Curriculum for Infection Control Practice. Dubuque: Kendall/Hunt, 1988 Abstracts and Presentations: 1. Oxner A, Myers A, Sinnott J, Marcet J, Sajdak J, Thompson P, Myers C. Non-Inferiority of a Novel Silver-Impregnated Dressing for Central Venous Catheters: A Retrospective Cohort Evaluating Rates of Central Line-Associated Bloodstream Infections in Adult Intensive Care Patients. Submitted to 49th Annual Meeting of IDSA, Boston, MA, Oct 2011 2. Sinnott, JT. Policy Implications for HIV/AIDS of the Ryan White CARE Act Reauthorization 2005. St. Louis: North American AIDS Treatment Access Forum (NATAF) Conference, 2006 12/12/2011 CURRICULUM VITAE John T. Sinnott, MD, FACP 26 3. Grafals M, Gompf S, Herman B, Tash K, Sinnott JT. Pseudomonas corneal ulcer: An ocular emergency. Jacksonville: American College of Physicians, Florida Chapter, 2004 4. Ganguly R, Toney JF, Quiroz E, Jacob S, Poblete SJ, Montero JA, Sinnott JT: HIV infection. Behavioral practices in a veteran population. Infectious Diseases Society of America, 1999 5. Ganguly R, Banerji M, Sinnott JT, Holt DA, Larkin JA, Houston SH, Quiroz E, Poblete S, Thomas G, Busciglio L. Influenza vaccine application in internal medicine clinics. Atlanta: American Society of Microbiology, 1998 6. Mastorides SM, Oehler RL, Greene JN, Sinnott JT, Sandin RL. Detection of mycobacterium tuberculosis by using air filtration and polymerase chain reaction. ACJP, 1998:470 7. Sinnott JT. Tuberculosis (TB) prevention strategy of physicians in residency training. San Francisco: Infectious Disease Society of America, 1998 8. Kneer C, Bradley EA, Poblete SA, Sinnott JT, Holt D, Ganguly. Practice of universal precautions guidelines (UVPG) in occupational settings. San Francisco: Infectious Diseases Society of America, 1998 9. Montero J, Mbaga I, Larkin JA, Sinnott JT, Shashy R, Ballow C: Enterococcal bacteremia: vancomycin resistant (VRE) compared to sensitive (VSE) strains. New Orleans: American Federation for Medical Research, 1998 10. Ganguly R, Sinnott JT, Houston SH, Toney JT, Holt DA, Cobian L. Hepatitis B virus vaccine: a measure against occupationally acquired infection. San Francisco: Infectious Disease Society of America, 1997 11. Vincent AL, Ayoub EM, Ottesen EA, Sinnott JT. Streptococci and Filariae as causes of lymphedema in Santo Domingo. San Francisco: Infectious Disease Society of America, 1997 12. Ganguly R, Toney JT, Holt DA, Sinnott JT, Carney M, Cobian L, Desai V: Occupational risks of hepatitis B virus infection among older health care providers (HCP). Tampa: 1997 Research Day, University of South Florida, 1997 13. Ganguly R, Sinnott JT, Carney M, Cobian L, Desai V, Toney J, Holt DA, Busciglio L, Callahan C, Mbaga I, Montero J. Occupational risks of hepatitis B virus infection. Miami: American Society for Microbiology, 1997 14. Ganguly R, Marty P, Herold A, Desai V, Anderson M, Sinnott JT, Holt DA, Larkin JA, Quiroz E, Callahan C, Mbaga I. Hepatitis B virus vaccine cost: a barrier to immunization. Miami: American Society for Microbiology, 1997 15. Larkin JA, Houston SH, Holt DA, Sinnott JT, Oehler R, Alexander LA. Reduction in contaminated allograft bone cultures by a tissue handling protocol. New Orleans: American Federation for Medical Research, 1997 16. Bergen G, Toney J, Oehler R, Houston SH, Ketch R, Vincent AL, Sinnott JT. The use of Thallium-201 scanning in the diagnosis of central nervous system lesions in HIV-infected persons. New Orleans: Infectious Diseases Society of America, 135, 1996 17. Yag-Howard C, Fitzmorris K, Pullara-Brandt T, Sinnott JT. Seabather's eruption in an individual not directly exposed to seawater. Baltimore: Southern Medical Association, 1996 12/12/2011 CURRICULUM VITAE John T. Sinnott, MD, FACP 27 18. Toney JF, Bergen GA, Sinnott JT, Vincent AL, Ganguly RA, Schmitt K, Wroten JE. Sexually transmitted diseases attitudes and knowledge in county public health care units. Tampa: National STD Prevention Conference, 1996 19. Toney JF, Bergen GA, Sinnott JT, Vincent AL, Ganguly RA. Sexually transmitted diseases attitudes and knowledge in county public health care units. New Orleans: The Infectious Disease Society of America, 1996 20. Ganguly RA, Marty P, Herold A, Carney M, Sinnott JT. Prevention of hepatitis B virus among university students. New Orleans: Infectious Disease Society of America, 1996 21. Vincent AL, Ganguly RA, Sinnott JT, Carney M, Hoechrel S. Knowledge and perception of AIDS transmission among Floridians. New Orleans: Infectious Disease Society of America, 1996 22. Larkin JA, Ison M, Houston SH, Clarkson E, Sakalosky P, Sinnott JT. Infection control plan reduces cardio-thoracic (CT) surgical site infections. New Orleans: Infectious Disease Society of America, 1996 23. Houston SH, Holt DA, Sinnott JT, Oehler R, Larkin JA, Alexander LA. Reduction in contaminated allograft bone cultures by a tissue handling protocol. New Orleans: Interscience Conference on Antimicrobial Agents and Chemotherapy, 1996 24. Houston SH, Oehler R, Holt DA, Sinnott JT, Bergen G, Ison MG. Education reduces contaminated blood cultures rates in a pediatric emergency department. New Orleans: Interscience Conference on Antimicrobial Agents and Chemotherapy, 1996 25. Houston SH, Ison MG, Willis D, Sinnott JT, Jani A. Cat-scratch disease – a case report and clinical update. Southern Medical Journal, 1995 26. Ganguly R, Herold A, Anderson M, Jani A, Sinnott JT. Hepatitis B infection among university students. Washington, DC: American Society for Microbiology, 1995 27. Vincent AL, Ganguly R, Sinnott JT, Hoecherl S. AIDS knowledge and acceptance by Floridians. San Francisco: Infectious Disease Society of America, 1995 28. Ison MG, Houston SH, Pattani S, Cobian L, Sinnott JT. Parvovirus B19 infection in cardiac transplant patients. San Francisco: Infectious Disease Society of America, 1995 29. Ganguly R, Vincent A, Sinnott JT, Hoecherl S. Influenza vaccination behavior among Floridians. San Francisco: Infectious Disease Society of America, 1995 30. Ganguly R, Vincent AL, Sinnott JT, Hoecherl S. Psychological perceptions about AIDS risks among Floridians. Las Vegas: American Society of Microbiologists, 1994 31. Rushton TC, Ganguly R, Sinnott JT, Banerji M. Pneumococcal vaccine acceptance in university-related clinics. Orlando: Infectious Disease Society of America, 1994 32. Kneer C, Sinnott JT, Bradley E, Ganguly R: Medical student exposure to body fluids. Orlando: Infectious Disease Society of America, 1994 33. Rushton TC, Ganguly R, Sinnott JT. Pneumococcal vaccine usage by internal medicine residents [Poster]. Orlando: Florida Chapter, American College of Physicians, 1993 34. Rushton TC, Ganguly R, Sinnott JT. Pneumococcal vaccine knowledge and attitude among internal medicine. New Orleans: American Society for Microbiology, 1993 12/12/2011 CURRICULUM VITAE John T. Sinnott, MD, FACP 28 35. Mayer CA, Cobian L, Ganguly R, Sinnott JT. Barriers to hepatitis B vaccination in HIV infected patients. New Orleans: Infectious Disease Society of America, 1993 36. Rushton TC, Ganguly R, Sinnott JT. Utilization of pneumococcal vaccine by internal medicine residents. New Orleans: Infectious Disease Society of America, 1993 37. Bergen GA, Sanders LI, Yangco BG, Sinnott JT. Lack of asymptomatic mycobacterium avium complex bacteremia in HIV infected patients with T-cell depletion. New Orleans: Interscience Conference on Antimicrobial Agents and Chemotherapy, 1993 38. Cobian L, Spoto V, Sinnott JT, Ganguly R. Immunoprophylaxis against occupational risk of hepatitis B infection. Chicago: American Academy of Allergy and Immunology, 1993 39. Mayer CA, Cobian L, Ganguly R, Sinnott JT, Villanueva L. Epidemiology and immunity to hepatitis B in HIV infected patients [Poster]. Tampa: College of Medicine Faculty Research Day, 1993 40. Rushton T, Ganguly R, Sinnott JT. Utilization of pneumococcal vaccine by internal medicine residents. New Orleans: Infectious Disease Society of America, 1993 41. Cancio M, Mayer C, Sinnott JT, Oehler R, Riter P, Holt DA. A simplified approach to controlling methicillin-resistant Staphylococcus aureus with Hibiclens and mupirocin in a chronic ventilatory care facility. Tampa: American College of Physicians, 1992 42. Spoto V, Greene J, Sandin R, Sinnott JT. Primary cutaneous filamentous fungal infections. Anaheim: Interscience Conference on Antimicrobial Agents and Chemotherapy, 1992 43. Farrell C, Spoto V, Fuller S, Bergen G, Sinnott JT, Ganguly R. Hepatitis B vaccination among the older health care providers. San Francisco: American Aging Association, 1992 44. Rushton TC, Ganguly R, Sinnott JT. Pneumococcal vaccine knowledge and attitude among internal medicine residents. Atlanta: American Society for Microbiology, 1992 45. Cobian L, Mayer CA, Villanueva LP, Sinnott JT, Ganguly R. Hepatitis B vaccine acceptance in HIV infected patients. Atlanta: American Society for Microbiology, 1992 46. Holt DA, Houston SH, Sinnott JT, Alexander LA, Oehler RL. The correlation of cadaveric blood cultures with bone cultures. San Diego: American Association of Tissue Banks, 1992 47. Spoto VM, Greene JN, Sandin R, Hiemenz J, Sinnott JT. Lactobacillus casei: A newly described cause of bacteremia in neutropenic patients [Poster]. Tampa: American College of Physicians, 1992 48. Mayer CA, Ganguly R, Sinnott JT: Hepatitis B: Immunity and Infection in HIV Infected Patients. Naples: American Association of Osteopathic Internists, 1992 49. Spoto V, Cobian L, Shea JM, Sinnott JT, Ganguly R. Hepatitis B vaccination in elderly health care providers. New Orleans: American Society for Microbiology, 1992 50. Holt DA, Houston SH, Sinnott JT, Alexander LA, Oehler RL. The correlation of cadaveric blood cultures with bone cultures. Anaheim: Interscience Conference on Antimicrobial Agents and Chemotherapy, 1992 51. Spoto V, Farrell C, Cobian L, Sinnott JT, Ganguly R. Hepatitis B in elderly health care providers [Poster]. Tampa: University of South Florida College of Medicine Research Day, 1992 52. Spoto V, Cobian L, Shea JP, Sinnott JT, Ganguly R. Hepatitis B vaccination in elderly health care providers. Baltimore: Society for Healthcare Epidemiology of America, 1992 12/12/2011 CURRICULUM VITAE John T. Sinnott, MD, FACP 29 53. Toney JF, Sinnott JT, Holt DA, Greene J, Seeley P. Chlamydia one dose treatment with azithromycin. Baltimore: American Federation for Clinical Research, 1992 54. Kneer C, Sinnott JT, Shaw K. Percutaneous and mucocutaneous exposure of third year medical students to blood and blood-tinged body fluids. Chicago: Interscience Conference on Antimicrobial Agents and Chemotherapy, 1991 55. Cobian L, Sinnott JT, Shea JA, Ganguly R. Hepatitis B virus vaccine acceptance by the health care professionals [Poster]. Tampa: American College of Physicians Scientific Meeting. Florida Chapter, 1991 56. Ganguly R, Webster TB, Sinnott, JT, Chmel H. Immunization of the institutionalized elderly against pneumococcal infection. Denver: American Aging Association and the American College of Gerontology, 1991 57. Sinnott JT, Emmanuel PJ. Hepatitis C virus and bone transplantation. Atlanta: American Federation for Clinical Research, 1991 58. Holt DA, Rosemurgy AS, Finney R, Cameron D, Ganguly R, Sinnott JT. An alternative central access device in HIV-positive patients. Tampa: American College of Physicians, 1990 59. Sinnott JT, Holt DA. Nutritional perceptions of AIDS patients [Poster]. Tampa: American College of Physicians Scientific Meeting, Florida Chapter, 1990 60. Frankel M, Sinnott JT, Gustke K. Prediction of postoperative infection in revision total hip surgery. New Orleans: American Association for Orthopaedic Surgeons, 1990 61. Sinnott JT, Frankle M, Spiegel P, Cancio MR. Tuberculous osteomyelitis masked by concomitant staphylococcal infection. Newport: American Orthopaedic Association, 1990 62. Emmanuel PJ, Sinnott JT. The recovery of bacteria from frozen bone biopsies. New Orleans: American Federation for Clinical Research, 1990 63. Sinnott JT, Emmanuel PJ. Use of a bone protocol to evaluate pediatric osteomyelitis. New Orleans: American Federation for Clinical Research, 1990 64. Ganguly R, Russell D, Sinnott JT, Fuller S, Cameron DJ. Nutritional practice and perception among patients with HIV infection. Scarsdale: American College of Nutrition Annual Symposium, 1989 65. Sinnott JT, Riddle V, Cancio M. The role of sonification in processing bone cultures in patients with osteomyelitis. Houston: Interscience Conference on Antimicrobial Agents and Chemotherapy, 1989 66. Sinnott JT, Himelright IM, Chlamydia species strain TWAR. Northbrook: Clinical Digest Series, 1989 67. Riddle V, Sinnott JT. The culture and sonication of osteomyelitic bone. Tampa: Student Research Symposium, University of South Florida College of Medicine, 1989 68. Sinnott JT, Cullison JP, Sweeney MS, et al. Infectious complications associated with OKT3 use in cardiac transplantation. Los Angeles: The International Society for Heart Transplantation, 1988 69. Sweeney MS, Macris MP, Frazier OH, Sinnott JT, et al. Treatment of advanced cardiac allograft rejection. Boca Raton: Southern Thoracic Surgical Association, 1987 12/12/2011 CURRICULUM VITAE John T. Sinnott, MD, FACP 30 70. Sweeney MS, Sinnott JT, Cullison JP. The use of OKT3 for stubborn allograft rejection. An advance in clinical immunotherapy. New Orleans: International Society for Heart Transplantation, 1987 71. Cardiac Transplant Team (Sinnott JT). Florida's first transplant program - The second year [Poster]. New Orleans: International Society for Heart Transplantation, 1987 72. Cardiac Transplant Team (Sinnott JT). Florida's first transplant program [Poster Presentation]. New York: International Society for Heart Transplantation, 1986 73. Yangco BG, Sinnott JT, McClelland JJ, Craig CP, Palumbo JM. Clinical study comparing ceftazidime and cefamandole in lower respiratory tract infections. Las Vegas: Interscience Conference on Antimicrobial Agents and Chemotherapy, 1983 74. Sinnott JT, Craig CP. Mouse liver macrophages and lipopolysaccharide neutralization. Birmingham: The Journal of the Alabama Academy of Science, 1976 75. Sinnott JT. Effect of nitrous oxide on schedules of reinforcement. Augusta, Georgia: Psychological Association, 1970 Newspaper Articles: 1. Sinnott JT, Mundra L. Fever Serious Business [Letter]. Tampa Tribune, Nov 13, 2009 2. Sinnott JT, Mundra L. Salary Focus Lacks Insight [Letter]. Tampa Tribune, Jun 28, 2009 3. Sinnott JT, D‟Souza KR. Why India? [Editorial] Tampa Tribune, Mar 26, 2006 4. Sinnott JT, Degryse A. Emerging threats [Invited Editorial]. Tampa Tribune, Sept 29, 2002 (Reprinted in part by USA Today, Apr 4-6, 2003) 5. Sinnott JT, Degryse A. Man versus microbes [Invited Editorial]. Tampa Tribune, Mar 29, 2003. (Co-published by USA Today, Yahoo, and Biz wire) 6. Sinnott JT, Degryse A. Flu bug threatens public health [Invited Editorial]. Tampa Tribune, Jan 4, 2003 7. Kerstyn A, Sinnott JT. Life and Death on your Own Terms [Book Review]. Tampa Tribune, Oct 7, 2001 8. Sinnott JT, Houston SH, Larkin JA. Commissioners acted against public interest on health plan. Tampa Tribune, Jan 6, 2001 9. Cancio M, Bartels L, Sinnott JT, Wright C. Culbreath has served well. Saint Petersburg Times, 2000 10. Cancio M, Sinnott JT, Bartels LJ, Wright C. Doctors prescribe antidote for Tampa General‟s troubles. Tampa Tribune, 1999 11. Sinnott JT. The importance of hand washing. Tampa Tribune, Feb 1999 12. Sinnott JT. Glad for civilians in space. Tampa Tribune, Nov 4 1998 13. Sinnott JT. Bitter fruit [Letter]. Tampa Tribune, Dec 12, 1995 14. Sinnott JT, Houston SH. It's time for your vaccination update. Hillsborough Health Times, Tampa, Florida, May 30, 1995 12/12/2011 CURRICULUM VITAE John T. Sinnott, MD, FACP 31 15. Sinnott JT. Chicken pox can be serious if adults become infected. La Gaceta, Tampa, Florida, Apr 21, 1995 16. Sinnott JT. How much do you really know about the "flu"? La Gaceta, Tampa, Florida, Feb 10, 1995 Miscellaneous Creative Works: 1. Public Service Announcement, Bioterrorism, in conjunction with Department of Health, written, directed, and produced, 2009 2. Sinnott JT. Dr‟s Travel Kit, Co-produced with USF Health Public Affairs, 2007. Link to video podcasts: https://hscweb3.hsc.usf.edu/health/now/?p=401 3. Sepsis Protocol for Rapid Diagnosis and Treatment © 2007 John Sinnott, MD 4. Logan J, Sinnott JT. “Danger in the Flesh: Patients Infected with Life-threatening Bacteria Must Race the Clock to Save Life and Limb.” ABC News, January 11, 2007. http://abcnews.go.com/Health/story?id=2785223&page=1&CMP=OTC-RSSFeeds0312 (accessed April 16, 2010) 5. Pneumonia Protocol for Rapid Diagnosis and Treatment © 2006 John Sinnott, MD 6. Public Service Announcement, Herpes Infection, in conjunction with Department of Health, written, directed, and produced, 2004 7. Public Service Announcement, HIV, in conjunction with Department of Health, written, directed, and produced, 2003 8. Sinnott JT, Alexander E, Campbell M. Antibiogram: Percentage of strains susceptible to antimicrobial agents listed. Tampa General Hospital. 2003 - present 9. Sinnott JT. SARS protocol. Tampa General Hospital, March, 2003 10. Sinnott JT. RX: from your Chief of Staff. A time of change. Tampa General Healthcare, Tampa, Florida, Spring, 1995 11. Sinnott JT. A proposal for rewarding teaching, implementation committee. University of South Florida College of Medicine. Tampa, Florida, 1995 12. Sinnott JT. "The proper management of biomedical waste" [Videotape]. Agency for Healthcare Administration. Tallahassee, Florida, 1995 13. Larkin J, Sinnott JT. HIV post exposure prophylaxis protocol. Bay Area Practitioners in Infection Control, Tampa, Florida, 1994 14. Sinnott JT, Alexander LA. Florida statewide tissue serology testing standards. LifeLink Tissue Bank, Tampa, Florida, 1994 15. Holt DA, Toney JF, Sinnott JT. Reviews of cephalosporins and aztreonam. Southern Medical Association Dial Access Program, 1993 16. Sinnott JT. AIDS update [Video]. University of South Florida College of Medicine, Tampa, Florida, 1993 17. Sinnott JT, Holt DA. Neural transplant tissue processing protocol. Tampa General Hospital, Tampa, Florida, 1993 12/12/2011 CURRICULUM VITAE John T. Sinnott, MD, FACP 32 18. Sinnott JT, Holt DA. Fellows Manual. Division of Infectious Diseases. University of South Florida College of Medicine, Tampa, Florida, 1992-1995. (Yearly editions) 19. Sinnott JT. Infectious diseases: one day at a time. [Student Education Manual]. University of South Florida College of Medicine and Tampa General Hospital, Tampa, Florida, 1989 20. Rivers C, Palumbo JM, Sinnott JT. Exposure to: AIDS, hepatitis, tuberculosis, what to do. Tampa General Hospital Employee Health Services Guide, 1989 21. Sinnott JT, Immunosuppressed lung biopsy protocol. Tampa General Hospital, Tampa, Florida, 1989 22. Sinnott JT, Nixon L, Hill DA, et al. The American Medical Association and the American Medical Student Association Adolescent AIDS Educational Program. University of South Florida College of Medicine, AIDS curriculum for public schools, Outreach program for College of Medicine student body approved by Hillsborough County Board of Public Instruction, Tampa, Florida, 1988 23. Sinnott JT, Alexander LA. Bacteriology for the tissue procurement laboratory. LifeLink of Tissue Bank, Tampa, Florida, 1988 24. Sinnott JT, Rasp J, Arnold J. Facts on the HIV antibody test. Tampa General Hospital Patient Education Series, Tampa, Florida, 1988 25. Sinnott JT. Treatment of urinary tract infections with single-dose antimicrobials. South Med Assoc Dial Access Program, 1987 26. Sinnott JT. "How Infection Control Prepares for Joint Commission for Accreditation of Hospital" (Videotape). Joint Commission on Accreditation of Hospitals National Teleconference. Tampa, Florida, 1987 27. Sinnott JT. Bone protocol. Tampa General Hospital and Shriner's Hospital for Crippled Children, Tampa, 1987 Non-Published Creative Works: 1. Sinnott JT. Professionalism in Infectious Diseases. Sept 19, 2009. Podcast found at: www.idpodcasts.net 2. Sinnott JT. Q & A: Dr. John Sinnott on H1N1 (Swine) Flu [Video series], in conjunction with USF Health. Oct 2009. Found at: http//hscweb3.hsc.usf.edu/health/now/?p=5568 3. Sinnott JT, Thompson P. Guidance for Healthcare Workers on Swine Flu [Video series]. Oct 2009, found at: http://www.youtube.com/watch?v=xiscxJBqYKs 4. 20 Questions: John T. Sinnott, MD, FACP, Featured on the Student Doctor Network. Feb 13, 2008, found at: http://www.studentdoctor.net/2008/02/cover-your-mouth-when-you-sneeze/ 5. Sinnott JT. Travel Medicine for the Clinician. Jul 11, 2007. Podcast found at www.idpodcasts.net. 12/12/2011 CURRICULUM VITAE John T. Sinnott, MD, FACP 33 Research: Industry Grants: 1. Houston SH, Sinnott JT. The effects of formulary conversion from ceftazidime to cefepime on the in vitro sensitivities of Pseudomonas serginosa, Enterobacter cloacae, and Klebsiella pneumoniae to selected antibiotics. ($20,000) (90% effort), Enzon, 1999–2000 2. Houston SH, Larkin JA, Sinnott JT, Montero JA, Cancio MR, Ubillos S, Mayer C, Busciglio L. Open study of Synercid (quinupristin/dalfopristin) for emergency use, (20% effort). RhonePoulenc Rorer, 1999–2000 3. Houston SH, Sinnott JT, Larkin JA, Montero JA, et al. Linezolid for the Treatment of Vancomycin-Resistant Enterococcal Infections: A Double-Blind Trial. (20% effort). Pharmacia, 1999 4. Sinnott JT, Larkin JA, Houston SH: Antimicrobial Sensitivity to Respiratory Tract Pathogens, (20% effort). Bristol-Myers Squibb, 1999 5. Sinnott JT: Antimicrobial Activity and Spectrum Investigation of Eight Broad- Spectrum BLactam Drugs: A 1997 Surveillance Trail in 102 Medical Centers in the United States, (20% effort). Bristol Meyers Squibb, 1998 6. Sinnott JT: The National H pylori Screening Initiative, (50% effort). Abbott Laboratories, 1997 7. Larkin JA, Sinnott JT, et al. Surveillance of resistant gram-positive bacteremia in the U.S. National Nosocomial Surveillance Group, (30% effort). The Clinical Pharmacokinetics Laboratory, 1996. ($3,000) 8. Larkin JA, Nadler J, Sinnott JT, et al. Multi-center study to evaluate Nystatin in non-neutropic patients with Candidemia, (33% effort). Aronex, 1996. ($62,500) 9. Sinnott JT, Holt DA, Houston SH, Cancio M, Larkin JA, et al. A randomized, double blinded, placebo controlled trial of the presumptive use of fluconazole in febrile intensive care unit patients at risk for fungal infections, (30% effort). Pfizer, 1996. ($60,000) 10. Larkin JA, Holt DA, Houston SH, Sinnott JT. In vitro sensitivity of HIV claves to ritonavir (ABT-538). (50% effort). Abbott Laboratories, 1996 ($10,000) 11. Sinnott JT, et al: Fluconazole for empiric Treatment of Candidiasis, (50% effort). Pfizer Pharmaceutical, 1996 12. Lyman G, Sinnott JT, et al. The safety and efficacy of rhGM-CSF when administered to patients with neutropenia. Sandoz, 1995, (5% effort) 13. Larkin JA, Sinnott JT, Toney J. HIV Cost and utilization study, The Agency for Health Care Policy (AHCPR) and Research, (33% effort). Rand, 1995 – present. ($6,000) 14. Sinnott JT: Prevalence of Important Pathogens and Antimicrobial Activity of Parenteral Drugs at Numerous Medical Center in the United States: Study on the Threat of Emerging Resistances: Real or Perceived? (10% Effort). 1994 15. Sinnott JT: Fluoroquinolone Resistance Surveillance Group in U.S. Surveillance Study of Parenteral Antimicrobial Agents as Empiric Therapy of Pathogens, (10% effort), Elsevier, 1994 12/12/2011 CURRICULUM VITAE John T. Sinnott, MD, FACP 34 16. Toney JF, Sinnott JT, Holt DA, Greene JN: Safety Tolerance, Efficacy Study of Piperacillin/Tazobactam plus Tobramycin in Sepsis (20% effort). American Cyanamid, 1994 17. Toney JF, Sinnott JT, Holt DA, Greene JN: A Double-Blinded, Randomized, Multicenter, Comparative Study of Cefodizime versus Ceftriaxone in Pneumonia (20% effort). Upjohn Pharmaceuticals, 1994 18. Toney JF, Greene JN, Sinnott JT, Holt DA: Pentoxifylline versus Placebo for the Prevention of Amphotericin Nephrotoxicity, (20% effort). Hoechst Pharmaceuticals, 1994 19. Toney JF, Sinnott JT, Holt DA, Greene JN: Teicoplanin vs. Ceftriaxone in Skin Infections, (20% effort). Merrell Dow Pharmaceuticals, 1992 20. Greene JN, Sinnott JT, Holt DA, Toney JF: Pentoxifylline vs. Placebo in the Prophylaxis of Amphotericin B-induced Nephrotoxicity (20% effort). Hoechst Pharmaceuticals, 1992 21. Toney JF, Sinnott JT, Holt DA, Greene JN: Comparison of Cefaclor vs. Ofloxacin in Pneumonia / Bronchitis (20% effort). Ortho Pharmaceuticals, 1992 22. Toney JF, Sinnott JT, Holt DA, Greene JN: Piperacillin / Tazobactam and Tobramycin vs. Imipenem and Tobramycin in Septicemia (10% effort). American Cyanamid, 1992 23. Toney JF, Sinnott JT, Holt DA, Greene JN: Ceftriaxone vs. Cefodizime in the Treatment of Pneumonia (25% effort). Fujisawa Pharmaceuticals, 1992 24. Toney JF, Sinnott JT, Holt DA, Greene JN: Temafloxacin vs. Imipenem in the Treatment of Skin Infections (25% effort). Abbott Laboratories, 1992 25. Toney JF, Sinnott JT, Holt DA, Greene JN: Ampicillin / Sulbactam in the Treatment of Urinary Tract Infections (25% effort). Roerig Pharmaceuticals, 1992 26. Sinnott JT, Holt DA, Hurst JM, Greene JN, Rosemurgy AT: Randomized Trial of a Chimeric Anti-Endotoxin Monoclonal Antibody (33% effort). Centocor Corporation, 1991 27. Sinnott JT, Greene JN. Anti-endotoxin antibody in the treatment of patients with suspected gram-negative bacteremia and endotoxemia. Pfizer, 1987–1992, ($20,000) 28. Yangco BG, Sinnott JT, Holder CD, Toney JF, Cullison JP. Comparison of intravenous cefmetazole and cefoxitin in the treatment of urinary tract infections. (20% effort) Upjohn, 1987 29. Yangco BG, Sinnott JT, Holder CD, Toney JF, Cullison JP. Ceftazidime L-Arginine in the treatment of bacterial infections of the skin and blood. (20% effort) Glaxo, 1987 30. Yangco BG, Sinnott JT, Toney JF, Cullison JP, Cancio MR: BMY-28100 Versus Cefaclor in the Treatment of Urinary Tract Infections (20% effort). Bristol-Myers Pharmaceuticals, 1987 31. Yangco BG, Sinnott JT, Toney JF, Cullison JP, Cancio MR: BMY-28142 in the Treatment of Urinary Tract, Lower Respiratory Tract and Skin, Skin Structures Infections (20% effort). Bristol-Myers Pharmaceuticals, 1987 32. Yangco BG, Sinnott JT, Toney JF, Cullison JP, Cancio MR: CI-919 (Enoxacin) Versus Carbenicillin in Prostatitis (20% effort). Ortho Pharmaceuticals, 1987 33. Yangco BG, Sinnott JT, Toney JF, Cullison JP, Cancio MR: BMY-28100 versus Cefaclor in the Treatment of Skin and Skin Structure Infections (20% effort). Bristol-Myers Pharmaceuticals, 1987 12/12/2011 CURRICULUM VITAE John T. Sinnott, MD, FACP 35 34. Spiegel PG, Sinnott JT, Belsole RJ, et. al., Protocol to Determine and Compare the Efficacy and Tolerance of Gentamicin from Beads and Surgical Wire (Septopal) and Conventional Antibiotic Therapy for the Treatment of Chronic Osteomyelitis (25% effort). Richards Pharmaceuticals, 1986 35. Yangco BG, Sinnott JT, Holder CD, Toney JF, Cullison JP: Ceftazidime vs. Ceftazidime LArginine in Bacterial Infections of the Skin, Skin Structures and Blood (20% effort). Glaxo Pharmaceuticals, 1986 36. Yangco BG, Sinnott JT, Holder CD, Toney JF, Cullison JP: Efficacy, Safety, and Tolerability of Intramuscularly Administered Imipenem/Cilastatin (20% effort). Merck Pharmaceuticals, 1986 37. Yangco BG, Sinnott JT, Holder CD, Toney JF, Cullison JP: Ofloxacin vs. Amoxicillin in the Treatment of Upper Respiratory Tract Infections (20% effort). Ortho Pharmaceuticals, 1986 38. Yangco BG, Sinnott JT, Holder CD, Toney JF, Cullison JP: Comparison of the Safety and Efficacy of Ceftazidime vs. an Anti-Pseudomonal Penicillin and an Aminoglycoside in the Treatment of Hospital-Acquired Pneumonia (20% effort). SmithKline Pharmaceuticals, 1986 39. Yangco BG, Sinnott JT, Holder CD, Toney JF, Cullison JP: Cefuroxime versus Augmentin in the Treatment of Lower Respiratory Tract Infections (20% effort). Glaxo Pharmaceuticals, 1986 40. Yangco BG, Sinnott JT, Holder CD, Toney JF, Cullison JP: Comparison of Cefmetazole and Cefoxitin in the Treatment of Urinary Tract Infections (20% effort). Upjohn Pharmaceuticals, 1986 41. Yangco BG, Sinnott JT, Holder CD, Toney JF: An Open Non-comparative Trial of Enoxacin in Patients with Lower Respiratory Infections (25% effort). Miles Pharmaceuticals, 1985 42. Yangco BG, Sinnott JT, Craig CP, Holder CD, Toney JF: A Comparative Multi-Center Evaluation of Cefadroxil and Amoxicillin Therapy in the Treatment of Uncomplicated Urinary Tract Infections (20% effort). Bristol-Myers Pharmaceuticals, 1985 43. Yangco BG, Sinnott JT, Craig CP, Holder CD, Toney JF: A Multicenter Randomized Blinded Study Comparing Intravenously Administered Cefpiramide and Ceftizoxime (Cefizox) in the Treatment of Hospitalized Patients with Infections Caused by Susceptible Aerobic and Anaerobic Bacteria (20% effort). Wyeth Pharmaceuticals, 1985 44. Yangco BG, Craig CP, Sinnott JT, Holder CD, Toney JF: A Multicenter Open Study of the Efficacy, Safety and Tolerance of Primaxin in the Therapy of Presumed or Proven Bacterial Infections (20% effort). Merck Pharmaceuticals, 1985 45. Yangco BG, Sinnott JT, Holder CD, Toney JF, Cullison JP: Comparison of Cefmetazole and Cefoxitin in the Treatment of Pneumonia (20% effort). Upjohn Pharmaceuticals, 1985 46. Yangco BG, Sinnott JT, Holder CD, Toney JF, Cullison JP: A Comparative Study of the Safety and Efficacy of Ceftazidime vs. Tobramycin/Piperacillin in the Treatment of Hospital-Acquired Pneumonia (20% effort). Glaxo Pharmaceuticals, 1985 47. Yangco BG, Sinnott JT, Holder CD, Toney JF: A Multicenter Comparison of Apalcillin and Piperacillin in Combination with Gentamicin in the Treatment of Hospitalized Patients with Fever and Granulocytopenia (25% effort). Wyeth Pharmaceuticals, 1985 12/12/2011 CURRICULUM VITAE John T. Sinnott, MD, FACP 36 48. Yangco BG, Sinnott JT, Holder CD, Toney JF: A Randomized, Blinded Study Comparing Cefpiramide and Cefoperazone in the Treatment of Hospitalized Patients (25% effort). Wyeth Pharmaceuticals. 1985 49. Yangco BG, Sinnott JT, Holder CD, Toney JF: A Comparative Multicenter Evaluation of Cefadroxil and Amoxicillin Therapy in the Treatment of Uncomplicated Urinary Tract Infections (25% effort). Bristol Myers Pharmaceuticals, 1985 50. Holder CD, Craig CP, Yangco BG, Sinnott JT, Toney JF: Emergency Treatment of Pneumocystis carinii Pneumonia in Immunoincompetent Patients with Difluoromethylornithine (20% effort). Merrell Dow Pharmaceuticals, 1985 51. Yangco BG, Sinnott JT, Craig CP, Holder CD, Toney JF: Early Phase II Efficacy and Safety of Teicoplanin in Patients with Gram Positive Infections (20% effort). Merrell Dow Pharmaceuticals, 1985 52. Yangco BG, Craig CP, Sinnott JT, Holder CD, Toney JF: A Multicenter Open Study of the Efficacy, Safety, and Tolerance of Primaxin in the Therapy of Bacterial Infection (20% effort). Merck, Sharpe and Dohme Pharmaceuticals, 1985 53. Yangco BG, Craig CP, Sinnott JT, Holder CD, Toney JF: Multicenter Randomized, Blinded Study Comparing Cefpiramide and Ceftizoxime in the Treatment of Hospitalized Patients (20% effort). Wyeth Pharmaceuticals, 1985 54. Yangco BG, Sinnott JT, Toney JF, Holder CD: Cefpiramide versus Ceftizoxime in Bacteremic Patients (25% effort). Wyeth Pharmaceuticals, 1985 55. Sinnott JT, Yangco BG, Craig CP, Holder CD, Toney JF: Cefoperazone Sodium in the Treatment of Bone and Joint Infections (20% effort). Roerig Pharmaceuticals, 1985 56. Yangco BG, Sinnott JT, Holder CD, Toney JF: Ceftazidime versus Ceftazidime L-arginine in Bacterial Infections of the Skin, Skin Structures and Blood (25% effort). Glaxo Pharmaceuticals, 1984 57. Yangco, BG, Sinnott JT, Craig CP, Holder C, Norris D: Cefbuperazone in Lower Respiratory Tract, Infection (20% effort). Bristol Pharmaceuticals, 1984 58. Yangco BG, Craig CP, Sinnott JT, Holder C, Norris D: Cefuroxime Axetil versus Cefaclor in the Treatment of Infections of Skin or Skin Structure (20% effort). Glaxo Pharmaceuticals, 1984 59. Yangco BG, Craig CP, Sinnott JT, Holder C, Norris D: Pseudomonas aeruginosa Infections with:Cefsulodin or Piperacillin (20% effort). Abbott Laboratories, 1984 60. Yangco BG, Sinnott JT, Craig CP, Holder C, Norris D: Open Multicenter Study of Cefpiramide in Hospitalized Patients (20% effort). Wyeth Pharmaceuticals, 1983 61. Yangco BG, Craig CP, Sinnott JT, Norris DG: U-63196E versus Cefotaxime in the Treatment of Urinary Tract Infections (25% effort). Upjohn Pharmaceuticals, 1983 62. Yangco BG, Craig CP, Spiegel PG, Sinnott JT, McClelland JJ: Cefuroxime versus Cefazolin in of Bone and Joint Infections (20% effort). Glaxo Pharmaceuticals, 1983 63. Yangco BG, Craig CP, Sinnott JT, McClelland JJ: Cefotetan versus Moxalactam in the Treatment of Hospitalized Patients with Pneumonia (25% effort). Stuart Pharmaceuticals, 1983 12/12/2011 CURRICULUM VITAE John T. Sinnott, MD, FACP 37 64. Yangco BG, Craig CP, Sinnott JT, McClelland JJ: Cefoxitin versus Two Dosage Regimens of Cefotetan in Urinary Tract Infections (20% effort). Stuart Pharmaceuticals, 1983 65. Yangco BG, Craig CP, Sinnott JT, Holder CD, Toney JF: Cefpimizole vs. Cefoperazone in Lower Respiratory Tract Infection (20% effort). Upjohn Pharmaceuticals, 1983 66. Yangco BG, Sinnott JT, Craig CP: Addendum to: "A Multicenter Randomized Study to Compare the Efficacy and Safety of Ceftazidime and Cefamandole in the Treatment of Lower Respiratory Infections" to include treatment of skin and skin structure infections with or without bacteremia (33% effort). Glaxo Pharmaceuticals, 1982 67. Yangco BG, Craig CP, Sinnott JT, McClelland JJ: Ceftizoxime versus Moxalactam or Cefotaxime for Pneumonia in Patients at Risk (25% effort). SmithKline Pharmaceuticals, 1982 68. Yangco BG, Craig CP, Sinnott JT, McClelland JJ: A Comparative Study of Intravenous Cefotetan vs. Cefoxitin in the Treatment of Hospitalized Patients with Urinary Tract Infections (25% effort). Stuart Pharmaceuticals, 1982 69. Yangco BG, Sinnott JT, Craig CP: A Randomized Study to Comparing Ceftazidime and Cefamandole in the Treatment of Lower Respiratory Tract Infections (30% effort). Glaxo Pharmaceuticals, 1982 70. Yangco BG, Sinnott JT, Craig CP: Controlled Study Comparing Cefonicid with Cefazolin in Urinary Tract Infections (30% effort). SmithKline Pharmaceuticals, 1981 Grants (Federal, State, and Other): 1. Sinnott JT, Knox M, Beal J, et al. Hepatitis C Treatment Expansion Initiative Evaluation and Technical Assistance Center. Health Resources and Services Administration (HRSA), 2010 – 2014. ($1.6 M) 2. Sinnott JT, Menezes L: Training Program for Physician Leaders, Gansu Provincial Health Department, Gansu Province, Lanzhou, China, 2010. ($87,000) 3. Toney JF, Schmitt K, Sinnott JT: Florida STD/HIV Prevention Training Center (PTC) – region IV STD/HIV Prevention Training Center (Program Announcement 00031). Centers for Disease Control and Prevention, (5% effort), 2000 – 2005. ($268,000 yearly, 5 year renewal) 4. Sinnott JT, Menezes L, Naik E, & Wills T: Training Program on Disaster management, Emerging Infections and Trauma Care for Policy Planners and Physicians in resource limited settings. Government of Maharashtra, India. 05/05-7/05. ($55,200) 5. Sinnott JT, Menezes L: Impact of Methicillin Resistant Staphylococcus aureus (MRSA) on the Tampa Bay Community. Pfizer. TGH Foundation. 01/05. ($60,000) 6. Amuso P & Sinnott JT: State Health Laboratory Management. Florida Department of Health, (10% effort), 2004 – 2007. ($278,901) 7. Sinnott JT, Martin R: Laboratory Quick Reference Guide for Category A Biological Agents. Florida Department of Health, (5% effort), 2004. ($14,280) 8. Sinnott JT: Florida Infectious Disease Institute. Florida Department of Health, 2003 – present. ($1,000,000) 12/12/2011 CURRICULUM VITAE John T. Sinnott, MD, FACP 38 9. Sinnott JT, Montero JA: STD training development grant. Pfizer, (33% effort), 1999 – 2001. ($75,000 yearly) 10. Saba H, Larkin J, Sinnott JT, Gompf S: Region IV South Ryan White Care Act Title III, Hemophilia of Georgia (33% effort), 1999 – 2005. ($124,614) 11. Emmanuel P, Larkin J, Sinnott J, Gompf S: Ryan White Care Act Title I, Primary Care for Women, Infants, and Children (33% effort). 1999 – 2001. ($27,000) 12. Sinnott JT: Infection Control Grant. The Tampa General Hospital Auxiliary, (100% effort), 1998. ($3,000) 13. Larkin JA, Sinnott JT, Holt DA: Housing and Urban Development Grant for Multi-purpose facility for AIDS/HIV related services. Hillsborough County Public Health Unit, (50% effort), 1996. ($1,000,000) 14. Larkin JA, Shashy RG, Sinnott JT: Sexually Transmitted Diseases Faculty Expansion Program Grant (Announcement # 616). Centers for Disease Control and Prevention/Department of Health and Human Services, (33% effort), 1996. ($400,000) 15. Larkin JA, Sinnott JT, Toney J: HIV Cost and utilization study. The Agency for Health Care Policy (AHCPR) and Research, Rand, (30% effort), 1995 – 1998. ($6,000 yearly) 16. Sinnott JT, Houston SH, Holt DA: Primary Care Approach to HIV Management, Ryan White Title IV, Grant DHHS-BRH Human Rehabilitative Services, (40% effort), 1995 – 1996. ($12,000) 17. Sinnott JT: Medical Student Medical Research Grant, Tampa General Healthcare Foundation, Tampa, Florida, 1995. ($1000) 18. Sinnott JT, Holt DA, Cunningham B, Houston SH: Multidisciplinary Team Enhanced AIDS Management Models (TEAM). Ryan White Title IX, Grant DHHS-BRH# 890024-01-0, Human Rehabilitative Services, (40% effort), 1993 – 1998. ($14,000) 19. Sinnott JT, Holt DA, Houston SH, Sanders L: The Medical Student History and Physical Examination of the AIDS Patient: Focus on Attitude and Techniques. Florida AIDS Education Training Network, DHHS-BHP No.1 D35 PE 00101-02, Subcontract A, (25% effort), 1993. ($5,000) 20. Knox M, Sinnott JT: Florida AIDS Education and Training Network, DHHS-BHP No. 1 D35 PE00101-02 (subcontract 10% effort), 1992 – 2004. ($12,000) 21. Holt DA, Sinnott JT, Cancio MR: HIV Health Care Cost in Hospitalized Patients. United States Public Health Service, Grant #R067, Westat Research, (15% effort), 1991 –1992. ($10,000) Contracts (Divisional, Negotiated): 1. Sinnott JT, Holt D: Hillsborough County Health Department Management Contract. Florida Department of Health, 1996 – present ($604,500 yearly) 2. Sinnott JT: Laboratory Management Contract. Lifelink Bone and Tissue Bank. 2003 – 2008 ($24,000 yearly) 12/12/2011 CURRICULUM VITAE John T. Sinnott, MD, FACP 39 3. Sinnott JT: Infection Control Contract. Shriner‟s Children‟s Hospital. 2003 – present ($13,800 yearly) 4. Haight D, Sinnott JT: Polk County Health Department Management Contract. Florida Department of Health, 1997 – present ($162,391 yearly) 5. Sinnott JT: Infectious Disease Case Management. Tampa General Hospital, 1996 – present ($30,000 yearly) 6. Sinnott JT: Employee Health Medical Director. Tampa General Hospital, 1985 – present ($80,000 yearly) Miscellaneous Scholarly Activities: Faculty, Florida/Caribbean AIDS Education and Training Center, 2002-present Co-Sponsor, Yale University Drinking Water Symposium, New Haven, 2009 American College of Physicians, Speaker - Bioterrorism Speakers Bureau, 2007-2008 Keynote Speaker, Conversations with Influence, Tampa Bay Performing Arts Center, Leadership Tampa, 2006 Keynote Speaker, University of South Florida Mini-Med School, Tampa Bay Performing Arts Center, 2005 Keynote Speaker, State of Florida Epidemiologist Update, Sanford, 2004 Keynote Speaker, 3rd Annual Infection: Maximizing the Probability of Positive Outcomes Meeting, US Micron, Frisco, 2004 Keynote Speaker, Florida Infectious Disease Society, Longboat Key, 2002 Invited Lecturer, Florida Infectious Disease Society, Jacksonville, 1995 Invited Lecturer, American College of Physicians, Florida Scientific Meeting, Orlando, 1993 Question Author, American Board of Internal Medicine, Re-certification examination, Philadelphia, 1993 –1996 Consultant, Human Fetal Nigral Transplant Program, University of South Florida, Tampa General Hospital, Tampa, 1993 – 2001 Instructor, American College of Physicians, Medical Knowledge Program, Orlando, 1993 Invited Lecturer, Florida Medical Association, Palm Beach, 1993 –1994 Course Director, Chronic Fatigue Syndrome Update, Sarasota, 1992 Instructor, Internal Medicine Review Course, American College of Physicians, Lake Buena Vista, 1991 Judge, International Science and Engineering Student Competition, Intel, Orlando, 1991 Moderator, Infectious Diseases II. Southern Society, American Federation for Clinical Research, New Orleans, 1990 Advisor and Co-Founder, Adolescent AIDS Education Program. The American Medical Association, University of South Florida College of Medicine, Tampa, Florida, 1987 – 1996 12/12/2011 CURRICULUM VITAE John T. Sinnott, MD, FACP 40 Consultant, Hillsborough County: President's National Committee on AIDS Site Visit, Tampa, 1987 Instructor, Medical Knowledge Self-Assessment Program. American College of Physicians, Orlando, 1987 Invited Lecturer, Paraprofessional Counseling Service, University of South Florida, Tampa, 1984 –1986 12/12/2011
© Copyright 2024